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Abstract: Background: Endovascular aneurysm repair (EVAR) is the most commonly used
method to repair abdominal aortic aneurysm. EVAR can be performed using a variety
of anaesthetic techniques including general anaesthetic (GA), regional anaesthetic
(RA) and local anaesthetic (LA) but little is known about the effect each of these
anaesthetic modes have on patient outcome. Methods: Data from the United Kingdom
National Vascular Registry were analysed. All patients undergoing elective, standard
infra-renal EVAR between 1st January 2014 and the 31st December 2016 were
included. Patients with a symptomatic aneurysm treated semi-electively were excluded.
The primary outcome was in-hospital death within 30-days of surgery. Secondary
outcomes included postoperative complications and length of hospital stay. Time-to-
event outcomes were compared using Cox Proportional Hazards regression adjusted
for confounders including British Aneurysm Repair score and chronic lung disease.
Results: A total of 9783 patients received an elective, standard infra-renal EVAR (GA
n=7069, RA n=2347 and LA n=367) across 89 hospitals. RA and/or LA was used in 82
hospitals. There were 64 in-hospital deaths within 30-days, 50 (0.9% mortality at 30-
days, 95% confidence interval [0.7%, 1.2%]) GA, 11 (0.6% [0.3%, 1.1%]) RA and 3
(1.5% [0.5%, 4.7%]) LA. The mortality was significantly lower in the RA group
compared to the GA group (adjusted hazard ratio RA/GA: 0.37 [0.17,0.81] (p=0.03);
LA/GA: 0.63 [0.15, 2.69]). Median length of stay was 2 days, but patients were
discharged from hospital more quickly in the RA and LA groups compared to the GA
(adjusted hazard ratio RA/GA: 1.10 [1.03, 1.17]; LA/GA: 1.15 [1.02, 1.29]). Pulmonary
complications occurred with similar frequency (overall 2.4%, adjusted odds ratio
RA/GA: 0.93 [0.66, 1.32]; LA/GA: 0.82 [0.41, 1.63]). Conclusion: 30-day mortality was
lower with RA compared to GA, but mode of anaesthesia was not associated with
increased complications for patients undergoing elective, standard infra-renal EVAR.
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MULTIPLE CHOICE QUESTION FOR EJVES Elective EVAR Paper  
 
Question A: 
Please select the correct answer. 
The current European Society for Vascular Surgery (ESVS) guidance guidelines on choice of mode of 
anaesthesia for elective infra renal EVAR recommends…….  
1. Local anaesthetic for elective EVAR.  
2. Regional anaesthetic for elective EVAR  
3. General anaesthetic for elective EVAR.  
4. General anaesthetic for patients with chronic lung disease   
5. Hospitals should use their local routine practice when choosing a mode of anaesthesia 
 
Questions B: 
Regarding choice of anaesthesia for elective EVAR, please select the correct answer. 
1. There is strong evidence that using local anaesthesia reduces pulmonary complications post 
elective EVAR.  
2.  Higher volume centres do a higher proportion of EVAR cases using local aesthetic.  
3. There is equipoise in the published literature regarding the choice of mode anaesthesia for 
elective EVAR and its effect on mortality and post-operative complications.  
4. The mortality benefit of using local anaesthesia in a ruptured EVAR can be extrapolated to the 
elective setting. 
5. Patients treated with regional anaesthesia or local anaesthesia stay in hospital longer than those 
treated with general anaesthesia. 
2 Multiple Choice Questions and 5 possible answers (highlight
correct answer)
MULTIPLE CHOICE QUESTION FOR EJVES Elective EVAR Paper  
 
Question A: 
Please select the correct answer. 
The current European Society for Vascular Surgery (ESVS) guidelines on choice of mode of 
anaesthesia for elective infra renal EVAR recommend…….  
1. Local anaesthetic for elective EVAR.  
2. Regional anaesthetic for elective EVAR  
3. General anaesthetic for elective EVAR.  
4. General anaesthetic for patients with chronic lung disease   
5. Hospitals should use their local routine practice when choosing a mode of anaesthesia 
 
Questions B: 
Regarding choice of anaesthesia for elective EVAR, please select the correct answer. 
1. There is strong evidence that using local anaesthesia reduces pulmonary complications post 
elective EVAR.  
2.  Higher volume centres do a higher proportion of EVAR cases using local aesthetic.  
3. There is equipoise in the published literature regarding the choice of mode anaesthesia for 
elective EVAR and its effect on mortality and post-operative complications.  
4. The mortality benefit of using local anaesthesia in a ruptured EVAR can be extrapolated to the 
elective setting. 
5. Patients treated with regional anaesthesia or local anaesthesia stay in hospital longer than those 
treated with general anaesthesia. 
2 Multiple Choice Questions and 5 possible answers (highlight
correct answer) non tracked
The effect of mode of anaesthesia on outcomes after elective endovascular 1 
repair of abdominal aortic aneurysm. 2 
 3 
G Dovell1,2, C A Rogers3, R Armstrong4, R A Harris3, R J Hinchliffe1,2 and R Mouton4 4 
 5 
1. Bristol Centre for Surgical Research, University of Bristol, UK. 6 
2. Department of Vascular Surgery, Southmead Hospital, Bristol, UK 7 
3. Clinical Trials and Evaluation Unit, Bristol Trials Centre, Bristol Medical School, University of 8 
Bristol, UK. 9 
4. Department of Anaesthesia, Southmead Hospital, Bristol, UK. 10 
 11 
Correspondence to: Mr George Dovell Bristol Centre for Surgical Research, University of Bristol, UK 12 
(e-mail: gd17321@bristol.ac.uk) 13 
Twitter: @georgedovell 14 
 15 
Submission Category: Original article 16 
 17 












Manuscript with tracked changes Click here to view linked References
What does this study add to the existing literature and how will it influence future clinical 30 
practice? 31 
 32 
This study supports the previously observed mortality benefit of regional anaesthetic (RA) technique 33 
for elective, standard infra-renal endovascular aneurysm repair (EVAR). Patients treated with local 34 
anaesthetic (LA) or LA and RA technique were discharged from hospital sooner. The previously 35 
observed reduction in pulmonary complications associated with LA technique in elective EVAR was 36 
not reproduced in this cohort. This retrospective analysis of a contemporary national database 37 
contributes to the evolving evidence base and clinical equipoise surrounding the choice of anaesthetic 38 






















ABSTRACT  61 
Background:  62 
Endovascular aneurysm repair (EVAR) is the most commonly used method to repair abdominal aortic 63 
aneurysm. EVAR can be performed using a variety of anaesthetic techniques including general 64 
anaesthetic (GA), regional anaesthetic (RA) and local anaesthetic (LA) but little is known about the 65 
effect each of these anaesthetic modes have on patient outcome. The aim of this study was to assess 66 
the effect of anaesthetic technique on early outcomes following elective EVAR.  67 
 68 
Methods: 69 
Data from the United Kingdom National Vascular Registry were analysed.  All patients undergoing 70 
elective, standard infra-renal EVAR between 1st January 2014 and the 31st December 2016 were 71 
included. Patients with a symptomatic aneurysm treated semi-electively were excluded. The primary 72 
outcome was in-hospital death within 30-days of surgery. Secondary outcomes included 73 
postoperative complications and length of hospital stay. Time-to-event outcomes were compared 74 
using Cox Proportional Hazards regression adjusted for confounders including British Aneurysm 75 
Repair score (a validated aneurysm risk prediction score which is calculated using age, sex, 76 
creatinine, cardiac disease, electrocardiogram, previous aortic surgery, white blood cell count, serum 77 
sodium, abdominal aortic aneurysm diameter and ASA grade) and chronic lung disease.  78 
 79 
Results: 80 
A total of 9783 patients received an elective, standard infra-renal EVAR (GA n=7069, RA n=2347 and 81 
LA n=367) across 89 hospitals. RA and/or LA was used in 82 hospitals. There were 64 in-hospital 82 
deaths within 30-days, 50 (0.9% mortality at 30-days, 95% confidence interval [0.7%, 1.2%]) in the 83 
GA group, 11 (0.6% [0.3%, 1.1%]) in the RA group and 3 (1.5% [0.5%, 4.7%]) in the LA group. The 84 
mortality rate differed between groups (p=0.03) and was significantly lower in the RA group compared 85 
to the GA group (adjusted hazard ratio RA/GA: 0.37 [0.17,0.81]; LA/GA: 0.63 [0.15, 2.69]). The 86 
median length of stay was 2 days for all modes of anaesthesia, but patients were discharged from 87 
hospital more quickly in the RA and LA groups compared to the GA group (adjusted hazard ratio 88 
RA/GA: 1.10 [1.03, 1.17]; LA/GA: 1.15 [1.02, 1.29]). Overall, 20.7% of patients experienced one or 89 
more complications (GA group: 22.1%; RA group: 16.8%, LA group: 17.7%) and pulmonary 90 
complications occurred with similar frequency in the three groups (overall 2.4%, adjusted odds ratio 91 
RA/GA: 0.93 [0.66, 1.32]; LA/GA: 0.82 [0.41, 1.63]).    92 
  93 
Conclusion:  94 
30-day mortality was lower with RA compared to GA, but mode of anaesthesia was not associated 95 
with increased complications for patients undergoing elective, standard infra-renal EVAR.  96 
 97 
Keywords: Elective Endovascular Aneurysm Repair, Anaesthesia, Abdominal Aortic Aneurysm  98 
  99 
INTRODUCTION  100 
 101 
The majority of elective abdominal aortic aneurysm (AAA) repairs are now performed using the 102 
endovascular aneurysm repair (EVAR) technique. EVAR has become the preferred method for 103 
elective surgical repair of AAA in the United Kingdom (UK) with 70% of elective AAA repairs 104 
performed using EVAR.1  105 
 106 
It is possible to carry out EVAR under different types of anaesthesia, including general (GA), regional 107 
(RA) and local anaesthesia (LA). Non-randomized studies have suggested potential patient benefit 108 
when local and/or regional techniques are used for EVAR.2,3 However, these studies included a mix of 109 
elective and emergency patients and results did not distinguish between elective and emergency 110 
EVAR.4,5,6  A recent systematic review examining mode of anaesthesia for EVAR (39,744 patients 111 
from 22 non-randomized studies) reported a lower unadjusted risk of death after emergency EVAR 112 
with LA compared to GA, but trends in elective EVAR were less clear.7 There are no randomized 113 
controlled trials to guide practice in this area therefore the best choice of anaesthetic technique 114 
remains unknown. 115 
 116 
There is emerging evidence from a recent randomized study (IMPROVE trial) that outcomes are 117 
better using LA in those patients presenting as an emergency with a rupture. A post-hoc subgroup 118 
analysis of a cohort of 186 patients who underwent emergency EVAR demonstrated a significantly 119 
reduced 30-day mortality for patients operated under LA compared to surgery under GA (odds ratio 120 
0·27, 95% confidence interval (CI) 0·10, 0·70, after adjustment for potential confounding factors).8 121 
The beneficial effect of LA in emergency EVAR observed in the IMPROVE trial was confirmed by a 122 
recent analysis of the UK National Vascular Registry (NVR), demonstrating a significant reduction in 123 
mortality in patients receiving ruptured AAA repair by EVAR under LA compared to GA (adjusted 124 
hazard ratio 0.62, 95% CI 0.45 to 0.85; P = 0.003).9 125 
 126 
The NVR captures data on more than 90% of AAA procedures in the UK. It provides a unique 127 
opportunity to examine the practice and outcomes of elective EVAR in a pragmatic real-world 128 
setting.10 The aim of this study was to quantify the use of different modes of anaesthesia for elective 129 
EVAR across all UK vascular centres, and to examine whether the observed benefit associated with 130 
LA for emergency EVAR was replicated in UK elective EVAR practice. 131 
 132 
 133 
  134 
METHODS 135 
 136 
National Vascular Registry  137 
 138 
The NVR was commissioned as part of the National Clinical Audit and Patient Outcomes Programme, 139 
by the Healthcare Quality Improvement Partnership (HQIP), to measure quality of care and outcomes 140 
for patients receiving vascular interventions in the National Health Service (NHS).1,10 Data submission 141 
forms part of the revalidation of NHS vascular surgeons and is therefore mandated. The NVR dataset 142 
is externally validated by comparing case ascertainment with Hospital Episode Statistics (HES); all 143 
NHS trusts in England are obliged to contribute to the HES dataset to ensure financial probity.11 The 144 
internal validity of the NVR is assessed using range and consistency checks, and by extensive data 145 
scrutiny, including checking data values with individual hospitals. The NVR also includes patients from 146 
Scotland, Wales and Northern Ireland, and equivalent case ascertainment comparisons are made 147 
with the Scottish Morbidity Record (SMR01), Patient Episode Database for Wales and the Hospital 148 
Activity Statistics for each demographic area respectively. As such the internal and external validity of 149 
the registry is satisfactory. The NVR remains the largest recognized register of AAA cases in the UK. 150 
Permission was obtained from HQIP for the NVR to release anonymized patient data under a data 151 
sharing agreement between HQIP and the University of Bristol. 152 
 153 
Study population  154 
 155 
The study population comprised of consecutive UK patients who underwent elective EVAR for an 156 
AAA between the 1st January 2014 and the 31st December 2016. Patients who were symptomatic, 157 
underwent complex EVAR, received EVAR for an indication other than AAA (for example dissection) 158 
and those patients undergoing a revision EVAR were excluded. 159 
 160 
The endovascular procedure performed is recorded at the time of surgery according to a range of 161 
Office of Population Censuses and Surveys (OPCS) codes in the NVR. Surgeons select whether the 162 
procedure was simple, complex or revision EVAR. Cases were excluded on the basis of this section; 163 
therefore, if a standard ‘simple’ EVAR was used in a patient with juxta renal aneurysm it is analysed 164 
as a standard infra-renal EVAR. 165 
The NVR case ascertainment rate for elective AAA over the period 2014 to 2016 was 89%. 1,10  166 
 167 
Mode of anaesthesia 168 
 169 
The modes of anaesthesia recorded in the NVR include GA, LA and RA. The NVR does not specify 170 
the exact quintessence of GA, RA or LA nor does it specify cases where a procedure was initiated 171 
under LA and then converted to GA (or RA) later in the procedure. 172 
 173 
Data collection  174 
 175 
Data items included in the NVR and available for analysis are summarized in Appendix 1. Data items 176 
were prospectively selected for extraction from the NVR. The NVR only collects data during the index 177 
hospital admission until discharge from the hospital where the vascular surgical procedure was 178 
carried out. Therefore, this could mean discharge home, or to a referring hospital or to a rehabilitation 179 
hospital. 180 
 181 
The British Aneurysm Repair (BAR) score, which includes data on age, sex, serum creatinine, cardiac 182 
disease, electrocardiogram, previous aortic surgery, white blood cell count, serum sodium, AAA 183 
diameter and ASA grade, was calculated from the available data. The BAR score is a validated risk 184 
prediction score that provides an estimate of the risk of in hospital mortality for patients undergoing 185 
elective AAA repair.12 The BAR score is summarised in Figure 1.  186 
 187 
Study outcomes  188 
 189 
The primary outcome for this study was in-hospital mortality to 30-days. Patients who were 190 
discharged from hospital alive were censored at last follow-up or 30-days if followed up beyond 30-191 
days. Secondary clinical outcomes included post-operative length of hospital stay (LOS), intensive 192 
care unit (ICU) admission, duration of ICU stay, post-operative complications, namely cardiac, 193 
pulmonary and cerebral complications, renal failure, postoperative bleeding, endoleak and 194 
readmissions following discharge.  We had not intended to consider readmissions, this was added in 195 
response to reviewer feedback. Secondary process outcomes included uptake of LA or RA for EVAR 196 
technique for elective AAA repair across UK vascular centres.  197 
 198 
Statistical analysis  199 
 200 
Continuous data are summarized as mean and standard deviation (SD) or median and interquartile 201 
range (IQR) if the distribution is skewed. Categorical data are summarized as a number and 202 
percentage. Patients undergoing EVAR are grouped by mode of anaesthesia, LA, GA or RA. 203 
Standardized mean differences (RA versus GA and LA versus GA) were calculated to quantify the 204 
differences in the baseline characteristics and aortic morphology between groups.  205 
 206 
Cox proportional hazards regression was used to compare time-to-event outcomes, i.e. time from 207 
surgery to in-hospital death within 30-days, discharge from ICU (for the subset admitted to ICU) and 208 
discharge from hospital after surgery, by mode of anaesthesia.  Patients who did not experience the 209 
event of interest were censored at discharge, 30-days or death as appropriate. Pulmonary 210 
complications were compared using logistic regression. This analysis was added following the 211 
publication of Van Orden et. al. report on pulmonary complications.13 All analyses were adjusted for 212 
presence of chronic lung disease (included because of an observed imbalance across the groups), 213 
BAR score12 and hospital to reduce the effect of confounding. For time-to-event outcomes the 214 
analysis was stratified by hospital. For the analysis of pulmonary complications hospital was included 215 
as a random effect. BAR score was fitted as a continuous variable. For the analysis of postoperative 216 
hospital stay the effect of BAR score changed over time and to accommodate this BAR score was 217 
modelled separately for each of days 1, 2, 3 and 4+ after surgery. Results are reported as hazard 218 
ratios (time-to-event outcomes) or odds ratios (binary outcome) with 95% confidence intervals (CI)  219 
comparing RA to GA and LA to GA. P-values are calculated for the overall effect of mode of 220 
anaesthesia, except where indicated otherwise.  Other outcomes are described but not formally 221 
compared. Missing data are described in the footnotes of tables.  222 
 223 
All analyses were performed in Stata version 15.1 (StataCorp LP, College Station, Tex).  224 
 225 
RESULTS 226 
The NVR captured data on 20,936 patients undergoing AAA repair between January 2014 and 227 
December 2016, 13,354 of whom received endovascular repair of their AAA. Of the 13,354 patients 228 
undergoing EVAR for AAA, 9783 (73.2%) received an elective, standard infra-renal EVAR. Most 229 
patients undergoing EVAR received GA (7069, 72.3%) with 2347 (23.9%) receiving RA and 367 230 
(3.8%) receiving LA (Figure 2).  231 
 232 
Hospital use of the three modes of anaesthesia 233 
EVAR procedures were carried out in 89 hospitals across the UK, 54 hospitals used all three methods 234 
of anaesthesia, 23 used GA or RA only, 3 used GA or LA only, 7 used GA alone and 2 used RA 235 
alone. There was a trend towards higher volume centres performing more procedures under LA or 236 
RA, however there was no increase in the proportion of cases performed under LA or RA as caseload 237 
increased (Table 1, Figure 3).  238 
 239 
Patient characteristics 240 
Table 2 summarizes patient demographics and co-morbidity by mode of anaesthesia. Over 88% of 241 
patients had co-morbidities and 7% of patients were considered American Society of 242 
Anaesthesiologists (ASA) IV or V. BAR score was 1.1%, 0.98% and 1.44% for the RA, GA and LA 243 
groups respectively. The median AAA diameter was 60mm (IQR 56-68mm). With the exception of 244 
chronic lung disease, which was lower in the GA group (1662, 23.5%) compared to the LA (133, 245 
36.2%) and RA (886, 36.9%) groups, patient characteristics were similar across the three groups, as 246 
indicated by a standardized mean difference of <0.2 for the factors examined.  247 
 248 
Clinical outcomes 249 
Overall, the mortality rate at 30-days following elective, standard infra-renal EVAR was 0.86% (95% 250 
confidence interval 0.67% to 1.11%). There were 64 in-hospital deaths within 30-days of surgery, 50 251 
in the GA group (0.9%, 95% CI 0.7%-1.2%]), 11 in the RA group (0.6%, 95% CI 0.3%-1.1%) and 3 252 
(1.5%, 95% CI 0.5%-4.7%) in the LA group (Figure 4). After adjustment for confounders including 253 
BAR score (Figure 1), chronic lung disease and hospital, the risk of death within 30-days differed 254 
significantly between the groups (p=0.03) and was significantly lower with RA compared to GA, 255 
(adjusted hazard ratio RA versus GA: 0.37, 95% CI 0.17-0.81; LA versus GA: 0.63, 95% CI 0.15-2.69) 256 
(Figure 5).  257 
 258 
Overall, 31.9% (2461 patients) were admitted to ICU post-operatively (Table 3). Amongst the subset 259 
admitted to ICU, the time to discharge was similar in the three groups, p=0.41, (Figure 5). In contrast, 260 
after adjustment for confounding (including BAR score, chronic lung disease and hospital), there was 261 
evidence to suggest that patients in the RA and LA groups were discharged from hospital more 262 
quickly than those in the GA group; adjusted hazard ratio RA versus GA: 1.10, 95% CI 1.03-1.17; LA 263 
versus GA: 1.15, 95% CI 1.02-1.29; p=0.003,  Figure 5). Pulmonary complications were recorded 264 
most frequently, occurring in 237 patients (2.4%) and was similar in the three groups (Figure 5). 265 
Endoleak was recorded in 1537 cases (15.7%), with type 2 endoleak occurring most frequently, in 266 




The main finding from this observational analysis of data from the UK NVR is that the 30-day in 271 
hospital mortality for elective, standard infra-renal EVAR was significantly lower in the RA group 272 
compared to the GA group (Figure 5). Mortality was also lower in the LA group, but not significantly 273 
so.  Patient groups were similar in demographics and co-morbid status. Complication rates were low 274 
and similar between groups, but patients in the RA and LA groups were more likely to be discharged 275 
earlier than those in the GA group.  276 
 277 
The use of local, regional and general anaesthesia techniques for EVAR is well established in both 278 
the elective and emergency settings.14 Recent evidence supports the use of LA for emergency EVAR 279 
of ruptured AAA: both the observational analysis of the IMPROVE trial and the analysis of the UK 280 
NVR demonstrated statistically significant reductions in mortality associated with the use of LA.8,9 The 281 
effect of mode of anaesthesia on outcomes following elective EVAR is unknown. The 2019 ESVS 282 
Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms 283 
recommends that anaesthesia for elective EVAR be chosen according to local hospital routine 284 
practice as well as individual patient preference and assessment. These recommendations are based 285 
on evidence from a small retrospective analysis published in 2015 (ENGAGE study)15, which 286 
demonstrated that there was no significant difference in mortality between the three modes of 287 
anaesthesia.16 Conversely, a recent systematic review comparing mortality across different modes of 288 
anaesthesia for EVAR found that there may be some evidence to suggest that mode of anaesthesia, 289 
in particular RA for elective EVAR and LA for emergency EVAR, is associated with improved 290 
outcomes.7 The lack of high-quality randomised data however, introduces a significant risk of bias. An 291 
observational analysis of the IMPROVE trial found that patients treated with EVAR for ruptured AAA 292 
using LA were discharged home sooner, as well as their discharge destination being more often 293 
directly home, when compared to GA.8 294 
 295 
Other contemporary authors have examined postoperative complications following EVAR and their 296 
relationship to mode of anaesthesia. In recent analysis of the Vascular Quality Initiative from the 297 
United States, the authors concluded that the use of LA for percutaneous elective EVAR was 298 
associated with fewer pulmonary complications (OR 2.8; 95% CI 1.49-5.43; p=0.002).13 299 
There remain difficulties in this subject concerning firstly, the decision making and patient selection 300 
behind the choice of mode of anaesthesia, and secondly, the ambiguity in definitions of RA, GA and 301 
LA, particularly with regards to the addition of varying degrees of sedation to local or regional 302 
techniques.7,9 303 
 304 
The lower mortality rate observed with RA for elective EVAR is replicated in this UK NVR cohort of 305 
9,783 patients undergoing elective, standard infra-renal EVAR. There was a trend towards a mortality 306 
benefit for the LA group but this did not reach statistical significance. The reduction in pulmonary 307 
complications with the use of LA reported by Van Orden et. al. 13 was not seen in this cohort; indeed, 308 
the rate of pulmonary complications was similar in the three groups (figure 5). Conversely this 309 
analysis does support the finding from the IMPROVE trial analysis as patients undergoing EVAR with 310 
LA or RA technique were discharged sooner. 311 
 312 
The use of LA and RA technique in elective EVAR has been widely adopted throughout the UK with 313 
82 of the 89 hospitals performing at least one procedure under LA or RA. There was a trend towards 314 
the higher volume centres were performing more procedures under LA or RA, however the proportion 315 
of cases performed under LA or RA did not increase with caseload (Figure 3). Interestingly the 316 
highest volume centre performed most of its elective EVAR under GA (97% of cases). This is contrary 317 
to the findings in emergency EVAR where high volume centres were performing more cases under 318 
LA.9  319 
 320 
As with any registry data, the NVR is limited by its observational nature, the data collected and the 321 
data completeness. Whilst there are measures in place to ensure the internal and external validity of 322 
the NVR, including range checks and ratifying case ascertainment with HES data (estimated to be 323 
89%),1 the database is not independently externally validated, and HES data can be unreliable, this 324 
therefore limits the validity of the database. The authors were unable to cross reference the NVR with 325 
another external database to ensure its validity and this is important to consider when interpreting the 326 
findings. Despite this significant limitation the data remains valuable and is intended to generate 327 
clinical equipoise within the literature and lead to further high-quality randomised studies.  328 
 329 
Although we were able to account for patient factors through the inclusion of the BAR score and the 330 
presence of chronic lung disease in our analyses, there are other potential confounding factors that 331 
may influence the choice of mode of anaesthesia and outcome that were not included and are not 332 
captured in the registry. Missing data are minimal in this cohort (<2%), with the exception of post-333 
operative ICU admission, and multiple imputation was not considered necessary. Data on post-334 
operative ICU admission was missing in 1675 GA, 363 RA and 46 LA cases which may suggest that 335 
the true numbers admitted to ICU postoperatively are lower than reported here. 336 
 337 
The decision-making process surrounding the choice of anaesthetic technique for individual patients 338 
remains unclear and is a potential source of significant selection bias. For example, the method of 339 
vascular access (percutaneous or open cut-down) may influence the choice of anaesthetic technique 340 
and subsequent complications. It was not possible to investigate these factors as this information is 341 
not captured by the NVR. Furthermore, there remains ambiguity and inconsistency in the definition of 342 
anaesthetic techniques, particularly when intravenous sedation is used alongside LA or RA 343 
techniques. In a study conducted by Verhoeven et. al. up to 13% of patients receiving LA EVAR also 344 
received intravenous sedation or analgesia,17 but these data are not recorded by the NVR. Even 345 
within GA different outcomes have been reported for total intravenous anaesthesia techniques when 346 
compared with volatile anaesthetics.18 In addition, the NVR does not record when a procedure was 347 
converted from one mode of anaesthesia to another, adding a further potential source of bias.   348 
 349 
The NVR only collects mortality during the index hospital admission and any post-discharge deaths 350 
within 30-days will have been missed. Any missing or inaccurate mortality datapoints could potentially 351 
significantly affect the results as the numbers of deaths in each group are small. However, it must be 352 
noted that in multiple high profile EVAR trials there is a negligible difference between 30-day and in-353 
hospital mortality, suggesting that this is unlikely to be the case.19-22  Further to this, it is also possible 354 
that some post-operative complications within the perioperative period have not been captured. With 355 
regards to the LA group, it may simply be too small to demonstrate significant differences in mortality 356 
and morbidity. The NVR may have irreparable flaws in its conception but, despite these limitations, 357 
the data remains valuable and represents the largest individual cohort of elective EVAR analysed by 358 





This study contributes to the expanding evidence base surrounding the choice of anaesthetic 364 
technique for elective EVAR. It supports the current literature, ratifying the observed mortality benefit 365 
associated with RA technique in elective EVAR but does not replicate the observed reduction in 366 
pulmonary complications observed with LA technique in elective EVAR. This work is valuable in 367 
demonstrating the equipoise surrounding the choice of anaesthetic technique for elective EVAR and 368 
the need for a high quality randomized controlled trial comparing the different anaesthetic techniques.  369 
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What does this study add to the existing literature and how will it influence future clinical 30 
practice? 31 
 32 
This study supports the previously observed mortality benefit of regional anaesthetic (RA) technique 33 
for elective, standard infra-renal endovascular aneurysm repair (EVAR). Patients treated with local 34 
anaesthetic (LA) or RA technique were discharged from hospital sooner. The previously observed 35 
reduction in pulmonary complications associated with LA technique in elective EVAR was not 36 
reproduced in this cohort. This retrospective analysis of a contemporary national database contributes 37 
to the evolving evidence base and clinical equipoise surrounding the choice of anaesthetic technique 38 






















ABSTRACT  61 
Background:  62 
Endovascular aneurysm repair (EVAR) is the most commonly used method to repair abdominal aortic 63 
aneurysm. EVAR can be performed using a variety of anaesthetic techniques including general 64 
anaesthetic (GA), regional anaesthetic (RA) and local anaesthetic (LA) but little is known about the 65 
effect each of these anaesthetic modes have on patient outcome. The aim of this study was to assess 66 
the effect of anaesthetic technique on early outcomes following elective EVAR.  67 
 68 
Methods: 69 
Data from the United Kingdom National Vascular Registry were analysed.  All patients undergoing 70 
elective, standard infra-renal EVAR between 1st January 2014 and the 31st December 2016 were 71 
included. Patients with a symptomatic aneurysm treated semi-electively were excluded. The primary 72 
outcome was in-hospital death within 30-days of surgery. Secondary outcomes included 73 
postoperative complications and length of hospital stay. Time-to-event outcomes were compared 74 
using Cox Proportional Hazards regression adjusted for confounders including British Aneurysm 75 
Repair score (a validated aneurysm risk prediction score which is calculated using age, sex, 76 
creatinine, cardiac disease, electrocardiogram, previous aortic surgery, white blood cell count, serum 77 
sodium, abdominal aortic aneurysm diameter and ASA grade) and chronic lung disease.  78 
 79 
Results: 80 
A total of 9783 patients received an elective, standard infra-renal EVAR (GA n=7069, RA n=2347 and 81 
LA n=367) across 89 hospitals. RA and/or LA was used in 82 hospitals. There were 64 in-hospital 82 
deaths within 30-days, 50 (0.9% mortality at 30-days, 95% confidence interval [0.7%, 1.2%]) in the 83 
GA group, 11 (0.6% [0.3%, 1.1%]) in the RA group and 3 (1.5% [0.5%, 4.7%]) in the LA group. The 84 
mortality rate differed between groups (p=0.03) and was significantly lower in the RA group compared 85 
to the GA group (adjusted hazard ratio RA/GA: 0.37 [0.17,0.81]; LA/GA: 0.63 [0.15, 2.69]). The 86 
median length of stay was 2 days for all modes of anaesthesia, but patients were discharged from 87 
hospital more quickly in the RA and LA groups compared to the GA group (adjusted hazard ratio 88 
RA/GA: 1.10 [1.03, 1.17]; LA/GA: 1.15 [1.02, 1.29]). Overall, 20.7% of patients experienced one or 89 
more complications (GA group: 22.1%; RA group: 16.8%, LA group: 17.7%) and pulmonary 90 
complications occurred with similar frequency in the three groups (overall 2.4%, adjusted odds ratio 91 
RA/GA: 0.93 [0.66, 1.32]; LA/GA: 0.82 [0.41, 1.63]).    92 
  93 
Conclusion:  94 
30-day mortality was lower with RA compared to GA, but mode of anaesthesia was not associated 95 
with increased complications for patients undergoing elective, standard infra-renal EVAR.  96 
 97 
Keywords: Elective Endovascular Aneurysm Repair, Anaesthesia, Abdominal Aortic Aneurysm  98 
  99 
INTRODUCTION  100 
 101 
The majority of elective abdominal aortic aneurysm (AAA) repairs are now performed using the 102 
endovascular aneurysm repair (EVAR) technique. EVAR has become the preferred method for 103 
elective surgical repair of AAA in the United Kingdom (UK) with 70% of elective AAA repairs 104 
performed using EVAR.1  105 
 106 
It is possible to carry out EVAR under different types of anaesthesia, including general (GA), regional 107 
(RA) and local anaesthesia (LA). Non-randomized studies have suggested potential patient benefit 108 
when local and/or regional techniques are used for EVAR.2,3 However, these studies included a mix of 109 
elective and emergency patients and results did not distinguish between elective and emergency 110 
EVAR.4,5,6  A recent systematic review examining mode of anaesthesia for EVAR (39,744 patients 111 
from 22 non-randomized studies) reported a lower unadjusted risk of death after emergency EVAR 112 
with LA compared to GA, but trends in elective EVAR were less clear.7 There are no randomized 113 
controlled trials to guide practice in this area therefore the best choice of anaesthetic technique 114 
remains unknown. 115 
 116 
There is emerging evidence from a recent randomized study (IMPROVE trial) that outcomes are 117 
better using LA in those patients presenting as an emergency with a rupture. A post-hoc subgroup 118 
analysis of a cohort of 186 patients who underwent emergency EVAR demonstrated a significantly 119 
reduced 30-day mortality for patients operated under LA compared to surgery under GA (odds ratio 120 
0·27, 95% confidence interval (CI) 0·10, 0·70, after adjustment for potential confounding factors).8 121 
The beneficial effect of LA in emergency EVAR observed in the IMPROVE trial was confirmed by a 122 
recent analysis of the UK National Vascular Registry (NVR), demonstrating a significant reduction in 123 
mortality in patients receiving ruptured AAA repair by EVAR under LA compared to GA (adjusted 124 
hazard ratio 0.62, 95% CI 0.45 to 0.85; P = 0.003).9 125 
 126 
The NVR captures data on more than 90% of AAA procedures in the UK. It provides a unique 127 
opportunity to examine the practice and outcomes of elective EVAR in a pragmatic real-world 128 
setting.10 The aim of this study was to quantify the use of different modes of anaesthesia for elective 129 
EVAR across all UK vascular centres, and to examine whether the observed benefit associated with 130 
LA for emergency EVAR was replicated in UK elective EVAR practice. 131 
 132 
 133 
  134 
METHODS 135 
 136 
National Vascular Registry  137 
 138 
The NVR was commissioned as part of the National Clinical Audit and Patient Outcomes Programme, 139 
by the Healthcare Quality Improvement Partnership (HQIP), to measure quality of care and outcomes 140 
for patients receiving vascular interventions in the National Health Service (NHS).1,10 Data submission 141 
forms part of the revalidation of NHS vascular surgeons and is therefore mandated. The NVR dataset 142 
is externally validated by comparing case ascertainment with Hospital Episode Statistics (HES); all 143 
NHS trusts in England are obliged to contribute to the HES dataset to ensure financial probity.11 The 144 
internal validity of the NVR is assessed using range and consistency checks, and by extensive data 145 
scrutiny, including checking data values with individual hospitals. The NVR also includes patients from 146 
Scotland, Wales and Northern Ireland, and equivalent case ascertainment comparisons are made 147 
with the Scottish Morbidity Record (SMR01), Patient Episode Database for Wales and the Hospital 148 
Activity Statistics for each demographic area respectively. As such the internal and external validity of 149 
the registry is satisfactory. The NVR remains the largest recognized register of AAA cases in the UK. 150 
Permission was obtained from HQIP for the NVR to release anonymized patient data under a data 151 
sharing agreement between HQIP and the University of Bristol. 152 
 153 
Study population  154 
 155 
The study population comprised of consecutive UK patients who underwent elective EVAR for an 156 
AAA between the 1st January 2014 and the 31st December 2016. Patients who were symptomatic, 157 
underwent complex EVAR, received EVAR for an indication other than AAA (for example dissection) 158 
and those patients undergoing a revision EVAR were excluded. 159 
 160 
The endovascular procedure performed is recorded at the time of surgery according to a range of 161 
Office of Population Censuses and Surveys (OPCS) codes in the NVR. Surgeons select whether the 162 
procedure was simple, complex or revision EVAR. Cases were excluded on the basis of this section; 163 
therefore, if a standard ‘simple’ EVAR was used in a patient with juxta renal aneurysm it is analysed 164 
as a standard infra-renal EVAR. 165 
The NVR case ascertainment rate for elective AAA over the period 2014 to 2016 was 89%. 1,10  166 
 167 
Mode of anaesthesia 168 
 169 
The modes of anaesthesia recorded in the NVR include GA, LA and RA. The NVR does not specify 170 
the exact quintessence of GA, RA or LA nor does it specify cases where a procedure was initiated 171 
under LA and then converted to GA (or RA) later in the procedure. 172 
 173 
Data collection  174 
 175 
Data items included in the NVR and available for analysis are summarized in Appendix 1. Data items 176 
were prospectively selected for extraction from the NVR. The NVR only collects data during the index 177 
hospital admission until discharge from the hospital where the vascular surgical procedure was 178 
carried out. Therefore, this could mean discharge home, or to a referring hospital or to a rehabilitation 179 
hospital. 180 
 181 
The British Aneurysm Repair (BAR) score, which includes data on age, sex, serum creatinine, cardiac 182 
disease, electrocardiogram, previous aortic surgery, white blood cell count, serum sodium, AAA 183 
diameter and ASA grade, was calculated from the available data. The BAR score is a validated risk 184 
prediction score that provides an estimate of the risk of in hospital mortality for patients undergoing 185 
elective AAA repair.12 The BAR score is summarised in Figure 1.  186 
 187 
Study outcomes  188 
 189 
The primary outcome for this study was in-hospital mortality to 30-days. Patients who were 190 
discharged from hospital alive were censored at last follow-up or 30-days if followed up beyond 30-191 
days. Secondary clinical outcomes included post-operative length of hospital stay (LOS), intensive 192 
care unit (ICU) admission, duration of ICU stay, post-operative complications, namely cardiac, 193 
pulmonary and cerebral complications, renal failure, postoperative bleeding, endoleak and 194 
readmissions following discharge.  We had not intended to consider readmissions, this was added in 195 
response to reviewer feedback. Secondary process outcomes included uptake of LA or RA for EVAR 196 
technique for elective AAA repair across UK vascular centres.  197 
 198 
Statistical analysis  199 
 200 
Continuous data are summarized as mean and standard deviation (SD) or median and interquartile 201 
range (IQR) if the distribution is skewed. Categorical data are summarized as a number and 202 
percentage. Patients undergoing EVAR are grouped by mode of anaesthesia, LA, GA or RA. 203 
Standardized mean differences (RA versus GA and LA versus GA) were calculated to quantify the 204 
differences in the baseline characteristics and aortic morphology between groups.  205 
 206 
Cox proportional hazards regression was used to compare time-to-event outcomes, i.e. time from 207 
surgery to in-hospital death within 30-days, discharge from ICU (for the subset admitted to ICU) and 208 
discharge from hospital after surgery, by mode of anaesthesia.  Patients who did not experience the 209 
event of interest were censored at discharge, 30-days or death as appropriate. Pulmonary 210 
complications were compared using logistic regression. This analysis was added following the 211 
publication of Van Orden et. al. report on pulmonary complications.13 All analyses were adjusted for 212 
presence of chronic lung disease (included because of an observed imbalance across the groups), 213 
BAR score12 and hospital to reduce the effect of confounding. For time-to-event outcomes the 214 
analysis was stratified by hospital. For the analysis of pulmonary complications hospital was included 215 
as a random effect. BAR score was fitted as a continuous variable. For the analysis of postoperative 216 
hospital stay the effect of BAR score changed over time and to accommodate this BAR score was 217 
modelled separately for each of days 1, 2, 3 and 4+ after surgery. Results are reported as hazard 218 
ratios (time-to-event outcomes) or odds ratios (binary outcome) with 95% confidence intervals (CI)  219 
comparing RA to GA and LA to GA. P-values are calculated for the overall effect of mode of 220 
anaesthesia, except where indicated otherwise.  Other outcomes are described but not formally 221 
compared. Missing data are described in the footnotes of tables.  222 
 223 
All analyses were performed in Stata version 15.1 (StataCorp LP, College Station, Tex).  224 
 225 
RESULTS 226 
The NVR captured data on 20,936 patients undergoing AAA repair between January 2014 and 227 
December 2016, 13,354 of whom received endovascular repair of their AAA. Of the 13,354 patients 228 
undergoing EVAR for AAA, 9783 (73.2%) received an elective, standard infra-renal EVAR. Most 229 
patients undergoing EVAR received GA (7069, 72.3%) with 2347 (23.9%) receiving RA and 367 230 
(3.8%) receiving LA (Figure 2).  231 
 232 
Hospital use of the three modes of anaesthesia 233 
EVAR procedures were carried out in 89 hospitals across the UK, 54 hospitals used all three methods 234 
of anaesthesia, 23 used GA or RA only, 3 used GA or LA only, 7 used GA alone and 2 used RA 235 
alone. There was a trend towards higher volume centres performing more procedures under LA or 236 
RA, however there was no increase in the proportion of cases performed under LA or RA as caseload 237 
increased (Table 1, Figure 3).  238 
 239 
Patient characteristics 240 
Table 2 summarizes patient demographics and co-morbidity by mode of anaesthesia. Over 88% of 241 
patients had co-morbidities and 7% of patients were considered American Society of 242 
Anaesthesiologists (ASA) IV or V. BAR score was 1.1%, 0.98% and 1.44% for the RA, GA and LA 243 
groups respectively. The median AAA diameter was 60mm (IQR 56-68mm). With the exception of 244 
chronic lung disease, which was lower in the GA group (1662, 23.5%) compared to the LA (133, 245 
36.2%) and RA (886, 36.9%) groups, patient characteristics were similar across the three groups, as 246 
indicated by a standardized mean difference of <0.2 for the factors examined.  247 
 248 
Clinical outcomes 249 
Overall, the mortality rate at 30-days following elective, standard infra-renal EVAR was 0.86% (95% 250 
confidence interval 0.67% to 1.11%). There were 64 in-hospital deaths within 30-days of surgery, 50 251 
in the GA group (0.9%, 95% CI 0.7%-1.2%]), 11 in the RA group (0.6%, 95% CI 0.3%-1.1%) and 3 252 
(1.5%, 95% CI 0.5%-4.7%) in the LA group (Figure 4). After adjustment for confounders including 253 
BAR score (Figure 1), chronic lung disease and hospital, the risk of death within 30-days differed 254 
significantly between the groups (p=0.03) and was significantly lower with RA compared to GA, 255 
(adjusted hazard ratio RA versus GA: 0.37, 95% CI 0.17-0.81; LA versus GA: 0.63, 95% CI 0.15-2.69) 256 
(Figure 5).  257 
 258 
Overall, 31.9% (2461 patients) were admitted to ICU post-operatively (Table 3). Amongst the subset 259 
admitted to ICU, the time to discharge was similar in the three groups, p=0.41, (Figure 5). In contrast, 260 
after adjustment for confounding (including BAR score, chronic lung disease and hospital), there was 261 
evidence to suggest that patients in the RA and LA groups were discharged from hospital more 262 
quickly than those in the GA group; adjusted hazard ratio RA versus GA: 1.10, 95% CI 1.03-1.17; LA 263 
versus GA: 1.15, 95% CI 1.02-1.29; p=0.003,  Figure 5). Pulmonary complications were recorded 264 
most frequently, occurring in 237 patients (2.4%) and was similar in the three groups (Figure 5). 265 
Endoleak was recorded in 1537 cases (15.7%), with type 2 endoleak occurring most frequently, in 266 




The main finding from this observational analysis of data from the UK NVR is that the 30-day in 271 
hospital mortality for elective, standard infra-renal EVAR was significantly lower in the RA group 272 
compared to the GA group (Figure 5). Mortality was also lower in the LA group, but not significantly 273 
so.  Patient groups were similar in demographics and co-morbid status. Complication rates were low 274 
and similar between groups, but patients in the RA and LA groups were more likely to be discharged 275 
earlier than those in the GA group.  276 
 277 
The use of local, regional and general anaesthesia techniques for EVAR is well established in both 278 
the elective and emergency settings.14 Recent evidence supports the use of LA for emergency EVAR 279 
of ruptured AAA: both the observational analysis of the IMPROVE trial and the analysis of the UK 280 
NVR demonstrated statistically significant reductions in mortality associated with the use of LA.8,9 The 281 
effect of mode of anaesthesia on outcomes following elective EVAR is unknown. The 2019 ESVS 282 
Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms 283 
recommends that anaesthesia for elective EVAR be chosen according to local hospital routine 284 
practice as well as individual patient preference and assessment. These recommendations are based 285 
on evidence from a small retrospective analysis published in 2015 (ENGAGE study)15, which 286 
demonstrated that there was no significant difference in mortality between the three modes of 287 
anaesthesia.16 Conversely, a recent systematic review comparing mortality across different modes of 288 
anaesthesia for EVAR found that there may be some evidence to suggest that mode of anaesthesia, 289 
in particular RA for elective EVAR and LA for emergency EVAR, is associated with improved 290 
outcomes.7 The lack of high-quality randomised data however, introduces a significant risk of bias. An 291 
observational analysis of the IMPROVE trial found that patients treated with EVAR for ruptured AAA 292 
using LA were discharged home sooner, as well as their discharge destination being more often 293 
directly home, when compared to GA.8 294 
 295 
Other contemporary authors have examined postoperative complications following EVAR and their 296 
relationship to mode of anaesthesia. In recent analysis of the Vascular Quality Initiative from the 297 
United States, the authors concluded that the use of LA for percutaneous elective EVAR was 298 
associated with fewer pulmonary complications (OR 2.8; 95% CI 1.49-5.43; p=0.002).13 299 
There remain difficulties in this subject concerning firstly, the decision making and patient selection 300 
behind the choice of mode of anaesthesia, and secondly, the ambiguity in definitions of RA, GA and 301 
LA, particularly with regards to the addition of varying degrees of sedation to local or regional 302 
techniques.7,9 303 
 304 
The lower mortality rate observed with RA for elective EVAR is replicated in this UK NVR cohort of 305 
9,783 patients undergoing elective, standard infra-renal EVAR. There was a trend towards a mortality 306 
benefit for the LA group but this did not reach statistical significance. The reduction in pulmonary 307 
complications with the use of LA reported by Van Orden et. al. 13 was not seen in this cohort; indeed, 308 
the rate of pulmonary complications was similar in the three groups (figure 5). Conversely this 309 
analysis does support the finding from the IMPROVE trial analysis as patients undergoing EVAR with 310 
LA or RA technique were discharged sooner. 311 
 312 
The use of LA and RA technique in elective EVAR has been widely adopted throughout the UK with 313 
82 of the 89 hospitals performing at least one procedure under LA or RA. There was a trend towards 314 
the higher volume centres were performing more procedures under LA or RA, however the proportion 315 
of cases performed under LA or RA did not increase with caseload (Figure 3). Interestingly the 316 
highest volume centre performed most of its elective EVAR under GA (97% of cases). This is contrary 317 
to the findings in emergency EVAR where high volume centres were performing more cases under 318 
LA.9  319 
 320 
As with any registry data, the NVR is limited by its observational nature, the data collected and the 321 
data completeness. Whilst there are measures in place to ensure the internal and external validity of 322 
the NVR, including range checks and ratifying case ascertainment with HES data (estimated to be 323 
89%),1 the database is not independently externally validated, and HES data can be unreliable, this 324 
therefore limits the validity of the database. The authors were unable to cross reference the NVR with 325 
another external database to ensure its validity and this is important to consider when interpreting the 326 
findings. Despite this significant limitation the data remains valuable and is intended to generate 327 
clinical equipoise within the literature and lead to further high-quality randomised studies.  328 
 329 
Although we were able to account for patient factors through the inclusion of the BAR score and the 330 
presence of chronic lung disease in our analyses, there are other potential confounding factors that 331 
may influence the choice of mode of anaesthesia and outcome that were not included and are not 332 
captured in the registry. Missing data are minimal in this cohort (<2%), with the exception of post-333 
operative ICU admission, and multiple imputation was not considered necessary. Data on post-334 
operative ICU admission was missing in 1675 GA, 363 RA and 46 LA cases which may suggest that 335 
the true numbers admitted to ICU postoperatively are lower than reported here. 336 
 337 
The decision-making process surrounding the choice of anaesthetic technique for individual patients 338 
remains unclear and is a potential source of significant selection bias. For example, the method of 339 
vascular access (percutaneous or open cut-down) may influence the choice of anaesthetic technique 340 
and subsequent complications. It was not possible to investigate these factors as this information is 341 
not captured by the NVR. Furthermore, there remains ambiguity and inconsistency in the definition of 342 
anaesthetic techniques, particularly when intravenous sedation is used alongside LA or RA 343 
techniques. In a study conducted by Verhoeven et. al. up to 13% of patients receiving LA EVAR also 344 
received intravenous sedation or analgesia,17 but these data are not recorded by the NVR. Even 345 
within GA different outcomes have been reported for total intravenous anaesthesia techniques when 346 
compared with volatile anaesthetics.18 In addition, the NVR does not record when a procedure was 347 
converted from one mode of anaesthesia to another, adding a further potential source of bias.   348 
 349 
The NVR only collects mortality during the index hospital admission and any post-discharge deaths 350 
within 30-days will have been missed. Any missing or inaccurate mortality datapoints could potentially 351 
significantly affect the results as the numbers of deaths in each group are small. However, it must be 352 
noted that in multiple high profile EVAR trials there is a negligible difference between 30-day and in-353 
hospital mortality, suggesting that this is unlikely to be the case.19-22  Further to this, it is also possible 354 
that some post-operative complications within the perioperative period have not been captured. With 355 
regards to the LA group, it may simply be too small to demonstrate significant differences in mortality 356 
and morbidity. The NVR may have irreparable flaws in its conception but, despite these limitations, 357 
the data remains valuable and represents the largest individual cohort of elective EVAR analysed by 358 





This study contributes to the expanding evidence base surrounding the choice of anaesthetic 364 
technique for elective EVAR. It supports the current literature, ratifying the observed mortality benefit 365 
associated with RA technique in elective EVAR but does not replicate the observed reduction in 366 
pulmonary complications observed with LA technique in elective EVAR. This work is valuable in 367 
demonstrating the equipoise surrounding the choice of anaesthetic technique for elective EVAR and 368 
the need for a high quality randomized controlled trial comparing the different anaesthetic techniques.  369 
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WHAT THIS PAPER ADDS 
This study supports the previously observed mortality benefit of regional anaesthetic (RA) technique 
for elective, standard infrarenal endovascular aneurysm repair (EVAR). Patients treated with local 
anaesthetic (LA) or RA were discharged from hospital sooner. The previously observed reduction in 
pulmonary complications associated with LA in elective EVAR was not reproduced in this cohort. 
This retrospective analysis of a contemporary national database contributes to the evolving evidence 
base and clinical equipoise surrounding the choice of anaesthetic technique for EVAR.  
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Objective: Endovascular aneurysm repair (EVAR) is the most commonly used method to repair 
abdominal aortic aneurysms. EVAR can be performed using a variety of anaesthetic techniques, 
including general anaesthetic (GA), regional anaesthetic (RA), and local anaesthetic (LA), but little is 
known about the effects that each of these anaesthetic modes have on patient outcome. The aim of this 
study was to assess the effect of anaesthetic technique on early outcomes after elective EVAR.  
Methods: Data from the UK’s National Vascular Registry were analysed. All patients undergoing 
elective, standard infrarenal EVAR between 1 January 2014 and 31 December 2016 were included. 
Patients with a symptomatic aneurysm treated semi-electively were excluded. The primary outcome 
was in hospital death within 30 days of surgery. Secondary outcomes included postoperative 
complications and length of hospital stay. Time to event outcomes were compared using Cox 
proportional hazards regression adjusted for confounders, including British Aneurysm Repair score (a 
validated aneurysm risk prediction score that is calculated using age, sex, creatinine, cardiac disease, 
electrocardiogram, previous aortic surgery, white blood cell count, serum sodium, abdominal aortic 
aneurysm diameter, and American Society of Anaesthesiologists grade) and chronic lung disease.  
Results: A total of 9 783 patients received an elective, standard infrarenal EVAR (GA, n = 7 069; RA, 
n = 2 347; and LA, n = 367) across 89 hospitals. RA and/or LA was used in 82 hospitals. There were 
64 in hospital deaths within 30 days, 50 (0.9% mortality at 30 days, 95% confidence interval [CI] 0.7 – 
1.2) in the GA group, 11 (0.6%, 95% CI 0.3 – 1.1) in the RA group, and three (1.5%, 95% CI 0.5 – 
4.7) in the LA group. The mortality rate differed between groups (p = .03) and was significantly lower 
in the RA group compared with the GA group (adjusted hazard ratio [aHR] RA/GA 0.37 [95% CI 0.17 
– 0.81]; LA/GA 0.63 [95% CI 0.15 – 2.69]). The median length of stay was two days for all modes of 
anaesthesia, but patients were discharged from hospital more quickly in the RA and LA groups than 
those in the GA group (aHR RA/GA 1.10 [95% 1.03 – 1.17]; LA/GA 1.15 [95% CI 1.02 – 1.29]). 
Overall, 20.7% of patients experienced one or more complications (GA group, 22.1%; RA group, 
16.8%; LA group, 17.7%) and pulmonary complications occurred with similar frequency in the three 
groups (overall 2.4%, adjusted odds ratio RA/GA 0.93 [95% CI 0.66 – 1.32]; LA/GA 0.82 [95% CI 
0.41 – 1.63]).  
Conclusion: Thirty day mortality was lower with RA than with GA, but mode of anaesthesia was not 
associated with increased complications for patients undergoing elective, standard infrarenal EVAR.  
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The majority of elective abdominal aortic aneurysm (AAA) repairs are now performed using 
endovascular aneurysm repair (EVAR). EVAR has become the preferred method for elective surgical 
repair of AAA in the UK, with 70% of elective AAA repairs performed by EVAR.1  
It is possible to carry out EVAR under different types of anaesthesia, including general (GA), 
regional (RA), and local anaesthesia (LA). Non-randomised studies have suggested a potential patient 
benefit when local and/or regional techniques are used for EVAR.2,3 However, these studies included a 
mix of elective and emergency patients, and results did not distinguish between elective and 
emergency EVAR.4–6 A recent systematic review examining mode of anaesthesia for EVAR (39 744 
patients from 22 non-randomised studies) reported a lower unadjusted risk of death after emergency 
EVAR with LA versus GA, but trends in elective EVAR were less clear.7 There are no randomised 
controlled trials to guide practice in this area and therefore the best choice of anaesthetic technique 
remains unknown. 
There is emerging evidence from a recent randomised study (Immediate Management of 
Patients with Rupture: Open Versus Endovascular Repair [IMPROVE] trial) that outcomes are better 
using LA in those patients presenting as an emergency with a rupture. A post hoc subgroup analysis of 
a cohort of 186 patients who underwent emergency EVAR demonstrated a significantly reduced 30 
day mortality for patients operated on under LA compared with surgery under GA (odds ratio [OR] 
0.27, 95% confidence interval [CI] 0.10 – 0.70, after adjustment for potential confounding factors).8 
The beneficial effect of LA in emergency EVAR observed in the IMPROVE trial was confirmed by a 
recent analysis of the UK National Vascular Registry (NVR), demonstrating a significant reduction in 
mortality in patients undergoing ruptured AAA repair by EVAR with LA compared with GA (adjusted 
hazard ratio [aHR] 0.62, 95% CI 0.45 – 0.85; p = .003).9 
The NVR captures data on > 90% of AAA procedures in the UK. It provides a unique 
opportunity to examine the practice and outcomes of elective EVAR in a pragmatic real world 
setting.10 The aim of this study was to quantify the use of different modes of anaesthesia for elective 
EVAR across all UK vascular centres, and to examine whether the observed benefit associated with 




The NVR was commissioned as part of the National Clinical Audit and Patient Outcomes Programme, 
by the Healthcare Quality Improvement Partnership (HQIP), to measure quality of care and outcomes 
 
 
for patients receiving vascular interventions in the National Health Service (NHS).1,10 Data submission 
forms part of the revalidation of NHS vascular surgeons and is therefore mandated. The NVR dataset 
is externally validated by comparing case ascertainment with Hospital Episode Statistics (HES); all 
NHS Trusts in England are obliged to contribute to the HES data set to ensure financial probity.11 The 
internal validity of the NVR is assessed using range and consistency checks, and by extensive data 
scrutiny, including checking data values with individual hospitals. The NVR also includes patients 
from Scotland, Wales, and Northern Ireland, and equivalent case ascertainment comparisons are made 
with the Scottish Morbidity Record (SMR01), Patient Episode Database for Wales, and the Hospital 
Activity Statistics for each demographic area, respectively. As such, the internal and external validity 
of the registry is satisfactory. The NVR remains the largest recognised register of AAA cases in the 
UK. Permission was obtained from HQIP for the NVR to release anonymised patient data under a data 
sharing agreement between HQIP and the University of Bristol. 
 
Study population  
The study population comprised consecutive UK patients who underwent elective EVAR for an AAA 
between 1 January 2014 and 31 December 2016. Patients who were symptomatic, underwent complex 
EVAR, received EVAR for an indication other than AAA (e.g., dissection), and those undergoing a 
revision EVAR were excluded. 
The endovascular procedure performed is recorded at the time of surgery according to a range 
of Office of Population Censuses and Surveys codes in the NVR. Surgeons select whether the 
procedure was simple, complex, or revision EVAR. Cases were excluded on the basis of this section; 
therefore, if a standard “simple” EVAR was used in a patient with juxtarenal aneurysm it is analysed 
as a standard infrarenal EVAR. 
The NVR case ascertainment rate for elective AAA over the period 2014 – 2016 was 89%.1,10  
 
Mode of anaesthesia 
The modes of anaesthesia recorded in the NVR include GA, LA, and RA. The NVR does not specify 
the exact quintessence of GA, RA, or LA, nor does it specify cases where a procedure was initiated 
under LA and then converted to GA (or RA) later in the procedure. 
 
Data collection  
Data items included in the NVR and available for analysis are summarized in Appendix S1 (see 
Supplementary Material). Data items were prospectively selected for extraction from the NVR. The 
NVR only collects data during the index hospital admission until discharge from the hospital where the 
 
 
vascular surgical procedure was carried out. Therefore, this could mean discharge home, to a referring 
hospital, or to a rehabilitation hospital. 
The British Aneurysm Repair (BAR) score, which includes data on age, sex, serum creatinine, 
cardiac disease, electrocardiogram, previous aortic surgery, white blood cell count, serum sodium, 
AAA diameter, and American Society of Anaesthesiologists (ASA) grade, was calculated from the 
available data. The BAR score is a validated risk prediction score that provides an estimate of the risk 
of in hospital mortality for patients undergoing elective AAA repair.12 The BAR score is summarised 
in Figure 1.  
 
Study outcomes  
The primary outcome for this study was in hospital mortality to 30 days. Patients who were discharged 
from hospital alive were censored at last follow up or 30 days if followed up beyond 30 days. 
Secondary clinical outcomes included postoperative length of hospital stay, intensive care unit (ICU) 
admission, duration of ICU stay, postoperative complications (namely cardiac, pulmonary, and 
cerebral complications), renal failure, postoperative bleeding, endoleak, and re-admissions following 
discharge. It was not intended to consider re-admissions; this was added in response to reviewer 
feedback. Secondary process outcomes included uptake of LA or RA for EVAR for elective AAA 
repair across UK vascular centres.  
 
Statistical analysis  
Continuous data are summarised as mean ± standard deviation (SD) or median (interquartile range 
[IQR]) if the distribution was skewed. Categorical data are summarised as n (%). Patients undergoing 
EVAR were grouped by mode of anaesthesia (LA, GA, or RA). Standardised mean differences (RA vs 
GA and LA vs GA) were calculated to quantify the differences in the baseline characteristics and aortic 
morphology between groups.  
Cox proportional hazards regression was used to compare time to event outcomes, that is, time 
from surgery to in hospital death within 30 days, discharge from ICU (for the subset admitted to ICU), 
and discharge from hospital after surgery, by mode of anaesthesia. Patients who did not experience the 
event of interest were censored at discharge, 30 days, or death as appropriate. Pulmonary 
complications were compared using logistic regression. This analysis was added following the report 
of Van Orden et al. on pulmonary complications.13 All analyses were adjusted for presence of chronic 
lung disease (included because of an observed imbalance across the groups), BAR score,12 and hospital 
to reduce the effect of confounding. For time to event outcomes the analysis was stratified by hospital. 
For the analysis of pulmonary complications hospital was included as a random effect. BAR score was 
 
 
fitted as a continuous variable. For the analysis of postoperative hospital stay the effect of BAR score 
changed over time; to accommodate this BAR score was modelled separately for each of days 1, 2, 3, 
and 4+ after surgery. Results are reported as hazard ratios (time to event outcomes) or ORs (binary 
outcome) with 95% CIs comparing RA with GA and LA with GA. P values were calculated for the 
overall effect of mode of anaesthesia, except where indicated otherwise. Other outcomes are described 
but not formally compared. Missing data are described in the table footnotes.  
All analyses were performed in Stata version 15.1 (StataCorp, College Station, TX, USA).  
 
RESULTS 
The NVR captured data on 20 936 patients undergoing AAA repair between January 2014 and 
December 2016, 13 354 of whom received endovascular repair of their AAA. Of the 13 354 patients 
undergoing EVAR for AAA, 9 783 (73.3%) received an elective, standard infrarenal EVAR. Most 
patients undergoing EVAR received GA (n = 7 069; 72.3%) with 2 347 (24.0%) receiving RA and 367 
(3.8%) receiving LA (Fig. 2).  
 
Hospital use of the three modes of anaesthesia 
EVAR procedures were carried out in 89 hospitals across the UK; 54 hospitals used all three methods 
of anaesthesia, 23 used GA or RA only, three used GA or LA only, seven used GA alone, and two 
used RA alone. There was a trend towards higher volume centres performing more procedures under 
LA or RA; however, there was no increase in the proportion of cases performed under LA or RA as 
case load increased (Table 1, Fig. 3).  
 
Patient characteristics 
Table 2 summarises patient demographics and comorbidity by mode of anaesthesia. Over 88% of 
patients had comorbidities and 7% of patients were considered to be ASA grade IV or V. BAR score 
was 1.1%, 0.98%, and 1.44% for the RA, GA, and LA groups, respectively. Median AAA diameter 
was 60 mm (IQR 56 – 68 mm). With the exception of chronic lung disease, which was lower in the 
GA group (n = 1 662; 23.5%) than in the LA (n = 133; 36.2%) and RA (n = 886; 36.9%) groups, 
patient characteristics were similar across the three groups, as indicated by a standardised mean 
difference of < 0.2 for the factors examined.  
 
Clinical outcomes 
Overall, the mortality rate at 30 days after elective, standard infrarenal EVAR was 0.9% (95% CI 0.67 
– 1.11). There were 64 in hospital deaths within 30 days of surgery: 50 in the GA group (0.9%, 95% 
 
 
CI 0.7 – 1.2), 11 in the RA group (0.6%, 95% CI 0.3 – 1.1), and three (1.5%, 95% CI 0.5 – 4.7) in the 
LA group (Fig. 4). After adjustment for confounders, including BAR score (Fig. 1), chronic lung 
disease, and hospital, the risk of death within 30 days differed significantly between the groups (p = 
.03) and was significantly lower with RA compared with GA (aHR RA vs GA 0.37 [95% CI 0.17 – 
0.81]; LA vs GA 0.63 [95% CI 0.15 – 2.69]) (Fig. 5).  
Overall, 31.9% (2 461 patients) were admitted to the ICU postoperatively (Table 3). Among 
the subset admitted to ICU, the time to discharge was similar in the three groups (p = .41) (Fig. 5). In 
contrast, after adjustment for confounding (including BAR score, chronic lung disease, and hospital), 
there was evidence to suggest that patients in the RA and LA groups were discharged from hospital 
more quickly than those in the GA group (aHR RA vs GA 1.10 [95% CI 1.03 – 1.17]; LA vs GA 1.15 
[95% CI 1.02 – 1.29]; p = .003) (Fig. 5). Pulmonary complications were recorded most frequently, 
occurring in 237 patients (2.4%) and was similar in the three groups (Fig. 5). Endoleak was recorded in 
1 537 cases (15.7%), with type 2 endoleak occurring most frequently, in 985 cases (63.3%) (Table 3).  
 
DISCUSSION 
The main finding from this observational analysis of data from the UK NVR is that the 30 day in 
hospital mortality for elective, standard infrarenal EVAR was significantly lower in the RA group 
compared with the GA group (Fig. 5). Mortality was also lower in the LA group, but not significantly 
so. Patient groups were similar regarding demographics and comorbidity status. Complication rates 
were low and similar between groups, but patients in the RA and LA groups were more likely to be 
discharged earlier than those in the GA group.  
The use of LA, RA, and GA techniques for EVAR is well established in both elective and 
emergency settings.14 Recent evidence supports the use of LA for emergency EVAR of ruptured AAA: 
both the observational analysis of the IMPROVE trial and the analysis of the UK NVR demonstrated 
statistically significant reductions in mortality associated with the use of LA.8,9 The effect of mode of 
anaesthesia on outcomes following elective EVAR is unknown. The 2019 ESVS Clinical Practice 
Guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms recommend that 
anaesthesia for elective EVAR be chosen according to local hospital routine practice, as well as 
individual patient preference and assessment. These recommendations are based on evidence from a 
small retrospective analysis published in 2015 (ENGAGE study),15 which demonstrated that there was 
no significant difference in mortality between the three modes of anaesthesia.16 Conversely, a recent 
systematic review comparing mortality across different modes of anaesthesia for EVAR found that 
there may be some evidence to suggest that mode of anaesthesia, in particular RA for elective EVAR 
and LA for emergency EVAR, is associated with improved outcomes.7 However, the lack of high 
 
 
quality randomised data introduces a significant risk of bias. An observational analysis of the 
IMPROVE trial found that patients treated with EVAR for ruptured AAA using LA were discharged 
home sooner, as well as their discharge destination being more often home, when compared to GA.8 
Other contemporary authors have examined postoperative complications following EVAR and 
their relationship to mode of anaesthesia. In recent analysis of the Vascular Quality Initiative from the 
USA, the authors concluded that the use of LA for percutaneous elective EVAR was associated with 
fewer pulmonary complications (OR 2.8, 95% CI 1.49 – 5.43; p = .002).13 
There remain difficulties in this subject concerning, firstly, the decision making and patient 
selection behind the choice of mode of anaesthesia, and, secondly, the ambiguity in definitions of RA, 
GA, and LA, particularly with regard to the addition of varying degrees of sedation to local or regional 
techniques.7,9 
The lower mortality rate observed with RA for elective EVAR is replicated in this UK NVR 
cohort of 9 783 patients undergoing elective, standard infrarenal EVAR. There was a trend towards a 
mortality benefit for the LA group, but this did not reach statistical significance. The reduction in 
pulmonary complications with the use of LA reported by Van Orden et al.13 was not seen in this 
cohort; indeed, the rate of pulmonary complications was similar in the three groups (Fig. 5). 
Conversely, this analysis does support the finding from the IMPROVE trial analysis as patients 
undergoing EVAR with LA or RA technique were discharged sooner. 
The use of LA and RA in elective EVAR has been widely adopted throughout the UK, with 82 
of the 89 hospitals performing at least one procedure under LA or RA. There was a trend towards the 
higher volume centres performing more procedures under LA or RA; however, the proportion of cases 
performed under LA or RA did not increase with case load (Fig. 3). Interestingly, the highest volume 
centre performed most of its elective EVAR under GA (97% of cases). This is contrary to the findings 
in emergency EVAR, where high volume centres were performing more cases under LA.9  
As with any registry data, the NVR is limited by its observational nature, the data collected, 
and the data completeness. While there are measures in place to ensure the internal and external 
validity of the NVR, including range checks and ratifying case ascertainment with HES data 
(estimated to be 89%),1 the database is not independently externally validated, and HES data can be 
unreliable, therefore limiting the validity of the database. The authors were unable to cross reference 
the NVR with another external database to ensure its validity and this is important to consider when 
interpreting the findings. Despite this significant limitation the data remain valuable and are intended 
to generate clinical equipoise within the literature and lead to further high quality randomised studies.  
Although the present study was able to account for patient factors through the inclusion of the 
BAR score and the presence of chronic lung disease in our analyses, there are other potential 
 
 
confounding factors that may influence the choice of mode of anaesthesia and outcome that were not 
included and are not captured in the registry. Missing data are minimal in this cohort (< 2%), with the 
exception of postoperative ICU admission, and multiple imputation was not considered necessary. 
Data on postoperative ICU admission were missing in 1 675 GA, 363 RA, and 46 LA cases, which 
may suggest that the true numbers admitted to ICU postoperatively are lower than reported here. 
The decision making process surrounding the choice of anaesthetic technique for individual 
patients remains unclear and is a potential source of significant selection bias. For example, the 
method of vascular access (percutaneous or open cut down) may influence the choice of anaesthetic 
technique and subsequent complications. It was not possible to investigate these factors as this 
information is not captured by the NVR. Furthermore, there remains ambiguity and inconsistency in 
the definition of anaesthetic techniques, particularly when intravenous sedation is used alongside LA 
or RA. In a study conducted by Verhoeven et al.,17 up to 13% of patients receiving LA EVAR also 
received intravenous sedation or analgesia,1 but these data are not recorded by the NVR. Even within 
GA different outcomes have been reported for total intravenous anaesthesia techniques when 
compared with volatile anaesthetics.18 In addition, the NVR does not record when a procedure was 
converted from one mode of anaesthesia to another, adding a further potential source of bias.  
The NVR only collects mortality during the index hospital admission and any postdischarge 
deaths within 30 days will have been missed. Any missing or inaccurate mortality data points could 
potentially significantly affect the results as the numbers of deaths in each group are small. However, it 
must be noted that in multiple high profile EVAR trials there is a negligible difference between 30 day 
and in hospital mortality, suggesting that this is unlikely to be the case.19–22 Further to this, it is also 
possible that some postoperative complications within the peri-operative period have not been 
captured. With regard to the LA group, it may simply be too small to demonstrate significant 
differences in mortality and morbidity. The NVR may have irreparable flaws in its conception but, 
despite these limitations, the data remain valuable and represent the largest individual cohort of 
elective EVAR analysed by mode of anaesthesia.  
 
Conclusions 
This study contributes to the expanding evidence base surrounding the choice of anaesthetic technique 
for elective EVAR. It supports the current literature, ratifying the observed mortality benefit associated 
with RA in elective EVAR but does not replicate the observed reduction in pulmonary complications 
observed with LA in elective EVAR. This work is valuable in demonstrating the equipoise 
surrounding the choice of anaesthetic technique for elective EVAR and the need for a high quality 





The authors express their thanks to all the vascular surgeons and patients who have contributed data to 
the National Vascular Registry (NVR). Thanks to Sam Waton from the Clinical Effectiveness Unit, 
Royal College of Surgeons of England, for performing the data retrieval from the NVR. 
 




This study was supported by an Infrastructure Grant from the David Telling Charitable Trust. 
 
REFERENCES 
1 Waton S, Johal A, Heikkila K, Cromwell D, Boyle J, Loftus I. National Vascular Registry: 2017 
Annual Report. London: Royal College of Surgeons of England, 2017. 
2 Edwards MS, Andrews JS, Edwards AF, Ghanami RJ, Corriere MA, Goodney PP, et al. Results of 
endovascular aortic aneurysm repair with general, regional and local/monitored anesthesia care in the 
American College of Surgeons National Surgical Quality improvement Program database. J Vasc Surg 
2011;54:1273–82.  
3 Bakker EJ, van de Luijtgaarden KM, van Lier F, Valentijn TM, Hoeks SE, Klimek M, et al. General 
anesthesia is associated with adverse cardiac outcome after endovascular aneurysm repair. Eur J Vasc 
Endovasc Surgery 2012;44:121–5. 
4 Ruppert V, Leurs LJ, Steckmeier B, Buth J, Umscheid T, Influence of anesthesia type on outcome 
after endovascular aortic aneurysm repair: an analysis based on EUROSTAR data. J Vasc Surg 
2006;44:16–21. 
5 Ruppert V, Leurs LJ, Rieger J, Steckmeier B, Buth J, Umscheid T, Risk-adapted outcome after 
endovascular aortic aneurysm repair: analysis of anesthesia types based on EUROSTAR data. J 
Endovasc Ther 2007;14:12–22.  
6 Karthikesalingam A, Thrumurthy SG, Young EL, Hinchliffe RJ, Holt PJE, Thompson MM. 
Locoregional anesthesia for endovascular aneurysm repair. J Vasc Surg 2012;56:510–19.  
7 Armstrong RA, Squire Y, Hinchliffe RJ, Rogers CA, Mouton R. Type of anaesthesia for 




8 IMPROVE trial investigators, Powell JT, Hinchliffe RJ, Thompson MM, Sweeting MJ, Ashleigh R, 
et al. Observations from the IMPROVE trial concerning the clinical care of patients with ruptured 
abdominal aortic aneurysm. Br J Surg 2014;101:216–24.  
9 Mouton R, Rogers CA, Harris RA, Hinchliffe RJ, Local anaesthesia for endovascular repair of 
ruptured abdominal aortic aneurysm. Br J Surg 2019;106:74–81. 
10 Vascular Society of Great Britain and Ireland. Vascular Services Quality Improvement Programme. 
Available at: https://www.vsqip.org.uk/reports/2018-annual-report/ (last accessed 2 March 2019). 
11 Office for National Statistics. The 21st century mortality files – deaths dataset, England and Wales 
2015. Available at: https://www. ons.gov.uk/peoplepopulationandcommunity/birthsdeathsand 
marriages/deaths/datasets/the21stcenturymortalityfilesdeathsdataset (last accessed 28 October 2017). 
12 Grant SW, Hickey GL, Grayson A D, Mitchell DC, McCollum CN, National risk prediction model 
for elective abdominal aortic aneurysm repair. Br J Surg 2013;100:645–53. 
13 Van Orden K, Farber A, Schermerhorn ML, Goodney PP, Kalish JA, Jones DW, et al. Local 
anesthesia for percutaneous endovascular abdominal aortic aneurysm repair is associated with fewer 
pulmonary complications. J Vasc Surg 2018;68:1023–9.  
14 IMPROVE Trial Investigators, Ulug P, Sweeting MJ, Gomes M, Hinchliffe RJ, Thompson MM, et 
al. Comparative clinical effectiveness and cost effectiveness of endovascular strategy v open repair for 
ruptured abdominal aortic aneurysm: three year results of the IMPROVE randomised trial BMJ 
2017;359:j4859.  
15 Broos PPHL, Stokmans RA, Cuypers PWM, van Sambeek MRHM, Teijink JAW, ENGAGE 
Investigators. Effects of anesthesia type on perioperative outcome after endovascular aneurysm repair. 
J Endovasc Ther 2015;22:770–7. 
16 Wanhainen A, Verzini F, Van Herzeele I, Allaire E, Brown M, Cohnert T, et al. Editor's Choice – 
European Society for Vascular Surgery (ESVS) 2019 Clinical Practice Guidelines on the Management 
of Abdominal Aorto-iliac Artery Aneurysms. Eur J Vasc Endovasc Surg 2019;57:8–93.  
17 Verhoeven ELG, Cinà CS, Tielliu IFJ, Zeebregts CJ, Prins TR, Eindhoven GB, et al. Local 
anesthesia for endovascular abdominal aortic aneurysm repair. J Vasc Surg 2005;42:402–9. 
18 Wigmore TJ, Mohammed K, Jhanji S, Long-term survival for patients undergoing 
volatile versus IV anesthesia for cancer surgery: a retrospective analysis. Anesthesiology 2016;124:69–
79. 
19 United Kingdom EVAR Trial Investigators, Greenhalgh RM, Brown LC, Powell JT, Thompson 




20 Becquemin JP, Pillet JC, Lescalie F, Sapoval M, Goueffic Y, Lermusiaux P, et al. A randomized 
controlled trial of endovascular aneurysm repair versus open surgery for abdominal aortic aneurysms 
in low- to moderate-risk patients. J Vasc Surg 2011;53:1167–73. 
21 Prinssen M, Verhoeven ELG, Buth J, Cuypers PWM, van Sambeek MRHM, Balm R, et al. A 
randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N 
Engl J Med 2004;351:1607–18. 
22 Lederle FA, Freischlag JA, Kyriakides TC, Matsumura JS, Padberg FT Jr, Kohler TR, et.al. Long-


























Table 1. Hospital use of anaesthesia according to abdominal aortic aneurysm (AAA) caseload 
 General anaesthesia Regional anaesthesia Local anaesthesia 
 Used for 
elective 
EVAR (n = 
87) 
Not used for 
elective 




EVAR (n = 
79) 
Not used for 
elective 




EVAR (n = 
57) 
Not used for 
elective 






























































Table 2. Patient and operative characteristics of patients receiving elective standard infrarenal 
endovascular aneurysm repair (n = 9 783) 
 GA (n = 7 
069)  










Mean ± SD age – y* 76.2 ± 7.2 77.0 ± 7.3 77.5 ± 7.4 0.11 0.19 
Male 6 229 (88.1) 2077 (88.5) 327 (89.1) 0.01 0.03 
Smoker      
Current or stopped 
< 2 mo 
1 361 (19.3) 420 (17.9) 60 (16.4) –0.04 –
0.07 
Ex  4 455 (63.0) 1 540 (65.6) 256 (69.8) 0.05 0.15 
Never 1 251 (17.7) 387 (16.5) 49 (13.4) –0.03 –
0.12 
ASA grade      
I (normal) 65 (0.9) 20 (0.9) 1 (0.3) –0.01 –
0.08 
II (mild disease) 1 789 (25.3) 498 (21.2) 58 (15.8) –0.10 –
0.24 
III (severe, not life 
threatening) 
4 808 (68.0) 1 633 (69.6) 236 (64.3) 0.03 –
0.08 
IV (severe, life 
threatening) 
403 (5.7) 195 (8.3) 70 (19.1) 0.10 0.41 
V (moribund 
patient) 
2 (0.0) 1 (0.0) 2 (0.5) 0.01 0.10 
Cardiovascular risk factors  
Comorbidity on 
admission (any) 
6 219 (88.0) 2 142 (91.3) 335 (91.3) 0.11 0.11 
Diabetes 1 146 (16.2) 401 (17.1) 67 (18.3) 0.02 0.05 
Hypertension 4 874 (68.9) 1 655 (70.5) 270 (73.6) 0.03 0.10 
 
 
Stroke 503 (7.1) 147 (6.3) 32 (8.7) –0.03 0.06 
Ischaemic heart disease 2 864 (40.5) 1 014 (43.2) 187 (51.0) 0.05 0.21 
Chronic heart failure 361 (5.1) 181 (7.7) 59 (16.1) 0.11 0.36 
Chronic renal disease 938 (13.3) 373 (15.9) 58 (15.8) 0.08 0.07 
Chronic lung disease 1 662 (23.5) 866 (36.9) 133 (36.2) 0.29 0.28 
AAA anatomy*  
AAA diameter – mm† 60 (56–66) 60 (56–65) 60 (57–68) 0.02 0.10 
Neck length – mm‡ 23 (17–30) 24 (17–30) 23 (17–30) –0.01 –
0.03 
Neck diameter – mm§ 24 (22–27) 24 (22–26) 24 (21–27) –0.07 –
0.10 
Common iliac artery 
diameter – mm|| 
15 (13–18) 15 (13–18) 15 (12–18) –0.02 –
0.06 







Data are presented as n (%) or median (interquartile range). GA = general anaesthesia; RA = regional 
anaesthesia; LA = local anaesthesia; SMD = standardised mean difference; AAA = abdominal aortic 
aneurysm. *Data missing for 32 patients (GA: 25; RA: 6; LA: 1). †Data missing for one patient (GA: 1; 
RA: 0; LA: 0). ‡Data missing for 212 patients (GA: 195; RA: 13; LA: 4). §Data missing for 208 
patients (GA: 191; RA: 13; LA: 4). ||Data missing for 206 patients (GA: 190; RA: 13; LA: 3). ¶Data 




Table 3. Postoperative outcomes for elective endovascular aneurysm repair 
 GA (n = 7 069) RA (n = 2 347) LA (n = 367) 
Outcomes 
In hospital death 
within 30 d* 
50 (0.9) 11 (0.6) 3 (1.5) 
7 d mortality 0.57 (0.4–0.8) 0.3 (0.1–0.6) 0.4 (0.1–2.6) 
30 d mortality 0.9 (0.7–1.2) 0.6 (0.3–1.1) 1.5 (0.5–4.7) 
Postoperative LOS – 
d†,‡ 
2.0 (2.0–4.0) 2.0 (1.0–4.0) 2.0 (1.0–4.0) 
Admitted to ICU§ 1 618 (30.0) 720 (36.3) 123 (38.3) 
If yes, ICU stay – 
d†,‡ 
1.0 (1.0–2.0) 1.0 (1.0–2.0) 1.0 (1.0–2.0) 
Re-admission within 
30 days of 
discharge*,‡ 
340 (5.8) 142 (6.8) 34 (10.9) 
Complications‡ GA (n = 7 068) RA (n = 2 346) LA (n = 367) 
Cardiac 
complications 
136 (1.9) 36 (1.5) 8 (2.2) 
Pulmonary 
complications 
163 (2.3) 63 (2.7) 11 (3.0) 
Cerebral 
complications 
12 (0.2) 6 (0.3) 1 (0.3) 
Renal failure 98 (1.4) 38 (1.6) 5 (1.4) 





0 5 504  (77.9) 1 953 (83.2) 302 (82.3) 
1 1 439 (20.4) 357 (15.2) 57 (15.5) 
2 101 (1.4) 31 (1.3) 6 (1.6) 
3 23 (0.3) 5 (0.2) 0 (0.0) 
4 1 (0.0) 0 (0.0) 2 (0.5) 
 
 
Endoleak|| 1 231 (17.6)  276 (11.8) 48 (13.1) 
Endoleak type¶ 
1 368 (29.9) 79 (28.6) 17 (35.4) 
2 776 (63.0) 185 (67.0) 24 (50.0) 
3 29 (2.4) 5 (1.8) 2 (4.2) 
4 27 (2.2) 2 (0.7) 3 (6.3) 
Unclassified 31 (2.5) 5 (1.8) 2 (4.2) 
Data are presented as n (%) or percentage (95% confidence interval) unless otherwise stated.  2 
GA = general anaesthesia; RA = regional anaesthesia; LA = local anaesthesia; LOS = length 3 
of stay; ICU = intensive care unit. *GA: n = 5 825; RA: n = 2 074; LA: n = 313. †Data are 4 
median (interquartile range). ‡Estimated using survival methods with patients censored if they 5 
died in hospital. §Excluding patients that died in theatre. ||GA: n = 6 992; RA: n = 2 343; LA: 6 























FIGURE LEGENDS 28 
Figure 1. British Aneurysm Repair score.12 29 
 30 
Figure 2. Elective endovascular aneurysm repair (EVAR): study profile. AAA = abdominal 31 
aneurysm repair. *n = 2 306/7 520 for ruptured AAA.  32 
 33 
Figure 3. Number of elective standard infrarenal endovascular aneurysm repair procedures 34 
by hospital. LA = local anaesthesia; GA = general anaesthesia; RA = regional anaesthesia.  35 
 36 
Figure 4. In hospital mortality to 30 days. RA = regional anaesthesia; GA = general 37 
anaesthesia; LA = local anaesthesia. 38 
 39 
Figure 5. Comparison of outcomes between groups. LA = local anaesthesia; GA = general 40 
anaesthesia; RA = regional anaesthesia; HR = hazard ratio; CI = confidence interval; OR = 41 




Risk Factors  
Type of Repair Open / EVAR 
Age Years 
Gender Male / Female 
Serum Creatinine Normal (≤120umol/L) 
Abnormal (> 120umol/L) 
Cardiac Disease (Ischaemic Heart Disease or Cardiac Failure) No / Yes 
Abnormal ECG No / Yes 
Previous aortic surgery or stent No / Yes 
White cell count (x 10^9) Normal (≥3.0 and ≤11.0) 
Abnormal (<3.0 or >11.0) 
Serum sodium (mmol/L) Normal (≥135 and ≤145) 
Abnormal (<135 or >145) 
AAA diameter (cm) Continuous variable 
ASA grade I, II, III, IV 
 
EVAR= Endovascular Aneurysm Repair. ECG= Electrocardiogram. AAA= Abdominal aortic aneurysm. ASA= 
American Society of Anaesthesiologists. 
Reference 12: Grant SW, Hickey GL, Grayson A D, Mitchell DC, McCollum CN, National risk prediction model for 
elective abdominal aortic aneurysm repair. Br J Surg. 2013; 100:645-653. 
 
  
Figure 1. British Aneurysm Repair Score 12 





























AAA= abdominal aortic aneurysm. EVAR= endovascular aneurysm repair. * 2306/7520 for ruptured AAA.
Patients for AAA repair between Jan 
2014 and Dec 2016 (n=20936) 
Patients excluded (n=7582) 
Open repair (n=7520*) 
Revision open repair (n=62) 
 
Patients excluded (n=2776) 
Complex EVAR (n=2283) 
Revision EVAR (n=431) 
Chronic dissection (n=25) 
Acute dissection (n=21) 
Unknown (n=1) 
Patients receiving an EVAR 
procedure (n=13354) 
Patients receiving a standard infra-
renal EVAR procedure (n=10578) 








Patients receiving elective standard 
infra-renal EVAR AAA repair (n=9783) 
Figure 2. Elective EVAR: study profile 
 
 
Figure 3. Number of elective standard infra-renal EVAR procedures by hospital, with hospital on the 
X axis and number of cases on the Y axis. Each bar is divided into colours which represent the 
proportion of cases performed by mode of anaesthesia.  
 
EVAR= Endovascular aneurysm repair. RA= Regional Anaesthesia. GA= General anaesthesia. LA= Local 
anaesthesia.   
 
 
Figure 4. In-hospital mortality to 30-days. 
 
 
RA= Regional Anaesthesia. GA= General anaesthesia. LA= Local anaesthesia.   
 
 
Figure 5. Comparison of outcomes between groups.  
 
RA= Regional Anaesthesia. GA= General anaesthesia. LA= Local anaesthesia. HR= Hazard Ratio. OR= Odds 





Risk Factors  
Type of Repair Open / EVAR 
Age Years 
Gender Male / Female 
Serum Creatinine Normal (≤120umol/L) 
Abnormal (> 120umol/L) 
Cardiac Disease (Ischaemic Heart Disease or Cardiac Failure) No / Yes 
Abnormal ECG No / Yes 
Previous aortic surgery or stent No / Yes 
White cell count (x 10^9) Normal (≥3.0 and ≤11.0) 
Abnormal (<3.0 or >11.0) 
Serum sodium (mmol/L) Normal (≥135 and ≤145) 
Abnormal (<135 or >145) 
AAA diameter (cm) Continuous variable 
ASA grade I, II, III, IV 
 
EVAR= Endovascular Aneurysm Repair. ECG= Electrocardiogram. AAA= Abdominal aortic aneurysm. ASA= 
American Society of Anaesthesiologists. 
 Reference 12: Grant SW, Hickey GL, Grayson A D, Mitchell DC, McCollum CN, National risk prediction 
model for elective abdominal aortic aneurysm repair. Br J Surg. 2013; 100:645-653. 
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AAA=: abdominal aortic aneurysm. , EVAR=: endovascular aneurysm repair.  
*1 2306/7520 for ruptured AAA.
Patients for AAA repair between Jan 
2014 and Dec 2016 (n=20936) 
Patients excluded (n=7582) 
Open repair (n=7520*1) 
Revision open repair (n=62) 
 
Patients excluded (n=2776) 
Complex EVAR (n=2283) 
Revision EVAR (n=431) 
Chronic dissection (n=25) 
Acute dissection (n=21) 
Unknown (n=1) 
Patients receiving an EVAR 
procedure (n=13354) 
Patients receiving a standard infra-
renal EVAR procedure (n=10578) 
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Figure 3. Number of elective standard infra-renal EVAR procedures by hospital, with hospital on the 
X axis and number of cases on the Y axis. Each bar is divided into colours which represent the 
proportion of cases performed by mode of anaesthesia.  
 
EVAR= Endovascular aneurysm repair. RA= Regional Anaesthesia. GA= General anaesthesia. LA= Local 
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Figure 4. In-hospital mortality to 30-days. 
 
 
RA= Regional Anaesthesia. GA= General anaesthesia. LA= Local anaesthesia. RA – regional anaesthesia, GA 
– general anaesthesia, LA local anaesthesia   
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Figure 5. Comparison of outcomes between groups.  
 
RA= Regional Anaesthesia. GA= General anaesthesia. LA= Local anaesthesia. HR= Hazard Ratio. OR= Odds 
Ratio. ICU= Intensive care unit. CI= Confidence interval. RA – regional anaesthesia, GA – general 
anaesthesia, LA local anaesthesia, HR – hazard ratio, OR – odds ratio, ICU – intensive care 
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Risk factors  
Type of repair Open/EVAR 
Age Years 
Sex Male/female 
Serum creatinine Normal (≤ 120 mol/L) 
Abnormal (> 120 
mol/L) 
Cardiac disease (ischaemic heart disease or cardiac failure) No/yes 
Abnormal ECG No/yes 
Previous aortic surgery or stent No/yes 
White cell count – 109 Normal (≥ 3.0 and ≤ 
11.0) 
Abnormal (< 3.0 or > 
11.0) 
Serum sodium – mmol/L Normal (≥ 135 and ≤ 
145) 
Abnormal (< 135 or > 
145) 
AAA diameter – cm Continuous variable 
ASA grade I, II, III, IV 
EVAR = endovascular aneurysm repair; ECG = electrocardiogram; AAA = abdominal aortic 
aneurysm; ASA = American Society of Anaesthesiologists. 
 





























Patients for AAA repair between 
January 2014 and December 2016 (n 
= 20 936) 
Patients excluded (n = 7 582) 
Open repair (n = 7 520)* 
Revision open repair (n = 62) 
 
Patients excluded (n = 2 776) 
Complex EVAR (n = 2 283) 
Revision EVAR (n = 431) 
Chronic dissection (n = 25) 
Acute dissection (n = 21) 
Unknown (n = 1) 
Patients receiving an EVAR 
procedure (n = 13 354) 
Patients receiving a standard 
infrarenal EVAR procedure (n = 10 
578) 
Patients excluded (n = 795)  
Ruptured (n = 795) 
Regional anaesthesia 
(n = 2 347) 
General anaesthesia 
(n = 7 069) 
Local anaesthesia (n 
= 367) 
Patients receiving elective standard 
infrarenal EVAR AAA repair (n = 9 
783) 
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Table 1. Hospital use of anaesthesia according to abdominal aortic aneurysm (AAA) caseload. 
 General Anaesthesia Regional Anaesthesia Local Anaesthesia 
 Used for 
elective 
EVAR (n=87) 


































































19.5 (8.9, 28.2) 
Data are presented as median (Interquartile range).  AAA= Abdominal aortic aneurysm. EVAR= Endovascular aneurysm 
repair.  
  





















Age (years) ‡ Mean (SD) 76.2 (7.2) 77.0 7.3 77.5 (7.4) 0.11 0.19 
Male  6229 (88.1) 2077 (88.5) 327 (89.1) 0.01 0.03 
Smoker 
Current or stopped <2 
months 
1361 (19.3) 420 (17.9) 60 (16.4) -0.04 -0.07 
 Ex  4455 (63.0) 1540 (65.6) 256 (70.1) 0.05 0.15 
 Never 1251 (17.7) 387 (16.5) 49 (13.4) -0.03 -0.12 
ASA grade I: Normal 65 (0.9) 20 (0.9) 1 (0.3) -0.01 -0.08 
 II: Mild disease 1789 (25.3) 498 (21.2) 58 (15.8) -0.10 -0.24 
 
III: Severe, not life-
threatening 




403 (5.7) 195 (8.3) 70 (19.1) 0.10 0.41 
 V: Moribund patient 2 (0.0) 1 (0.0) 2 (0.5) 0.01 0.10 
CARDIOVASCULAR RISK FACTORS*  
Comorbidity on admission (any) 6219 (88.0) 2142 (91.3) 335 (91.3) 0.11 0.11 
Diabetes 1146 (16.2) 401 (17.1) 67 (18.3) 0.02 0.05 
Hypertension 4874 (68.9) 1655 (70.5) 270 (73.6) 0.03 0.10 
Stroke 503 (7.1) 147 (6.3) 32 (8.7) -0.03 0.06 
Ischaemic heart disease 2864 (40.5) 1014 (43.2) 187 (51.0) 0.05 0.21 
Chronic heart failure 361 (5.1) 181 (7.7) 59 (16.1) 0.11 0.36 
Chronic renal disease 938 (13.3) 373 (15.9) 58 (15.8) 0.08 0.07 
Chronic lung disease 1662 (23.5) 866 (36.9) 133 (36.2) 0.29 0.28 
AAA ANATOMY†  
AAA diameter (mm) ¶  60 (56, 66) 60 (56, 65) 60 (57, 68) 0.02 0.10 
Neck length (mm) §  23 (17, 30) 24 (17, 30) 23 (17, 30) -0.01 -0.03 
Neck diameter (mm)×  24 (22, 27) 24 (22, 26) 24 (21, 27) -0.07 -0.10 
Common iliac artery 
diameter (mm) ~ 
 15 (13, 18) 15 (13, 18) 15 (12, 18) -0.02 -0.06 
BRITISH ANEURYSM REPAIR SCORE (BAR SCORE) †  











Data are presented as n (%)* or median (Interquartile range) † unless otherwise stated. RA= Regional Anaesthesia. GA= 
General Anaesthesia. LA = Local Anaesthesia. SMD = Standardized mean difference. EVAR = Endovascular aneurysm 
repair. AAA= abdominal aortic aneurysm.  
Missing data (GA, RA, LA): ‡ Data missing for 32 patients (25, 6, 1), ¶ data missing for 1 patient (1, 0, 0), § data missing for 
212 patients (195, 13, 4), × data missing for 208 patients (191, 13, 4), ~ data missing for 206 patients (190, 13, 3), ▪ data 





Table 3. Post-operative outcomes for elective EVAR. 
 General Anaesthesia 
n=7069  
 Regional Anaesthesia   
n=2347 
Local Anaesthesia  
n=367 
OUTCOMES    
In hospital death within 30-days† 50 (0.9) 11 (0.6) 3 (1.5) 
7-day mortality§  0.57 (0.4, 0.8) 0.3 (0.1, 0.6) 0.4 (0.1, 2.6) 
30-day mortality§  0.9 (0.7, 1.2) 0.6 (0.3, 1.1) 1.5 (0.5, 4.7) 
Post-op LOS 
(days) *¶ 
 2.0 (2.0, 4.0) 2.0 (1.0, 4.0) 2.0 (1.0, 4.0) 
Admitted to 
ICU^† 
 1618 (30.0) 720 (36.3) 123 (38.3) 
If yes, ICU stay 
(days) *¶ 
 1.0 (1.0, 2.0) 1.0 (1.0, 2.0) 1.0 (1.0, 2.0) 
Readmission within 30 days of 
discharge† 
340 (5.8) 142 (6.8) 34 (10.9) 
COMPLICATIONS† n=7068 n=2346 n=367 
Cardiac complications 136 (1.9) 36 (1.5) 8 (2.2) 
Pulmonary 
complications 
 163 (2.3) 63 (2.7) 11 (3.0) 
Cerebral 
complications 
 12 (0.2) 6 (0.3) 1 (0.3) 
Renal failure  98 (1.4) 38 (1.6) 5 (1.4) 
Bleeding  74 (1.0) 15 (0.6) 4 (1.1) 
        
Number of 
complications 
None 5504 (77.9) 1953 (83.2) 302 (82.3) 
1 1439 (20.4) 357 (15.2) 57 (15.5) 
 2 101 (1.4) 31 (1.3) 6 (1.6) 
 3 23 (0.3) 5 (0.2) 0 (0.0) 
 4 1 (0.0) 0 (0.0) 2 (0.5) 
        
Endoleak‡  1231 (17.6)  276 (11.8) 48 (13.2) 
Endoleak type‖ Type 1 368 (29.9) 79 (28.6) 17 (35.4) 
Type 2 776 (63.0) 185 (67.0) 24 (50.0) 
Type 3 29 (2.4) 5 (1.8) 2 (4.2) 
Type 4 27 (2.2) 2 (0.7) 3 (6.3) 
Unclassified 31 (2.5) 5 (1.8) 2 (4.2) 
Data are presented as n (%)†, percent (95% confidence interval)§ and median (Interquartile range)¶ unless otherwise 
stated. RA= Regional Anaesthesia. GA= General Anaesthesia. LA = Local Anaesthesia. LOS= Length of Stay. ICU= 
Intensive care unit.  EVAR= Endovascular aneurysm repair. * estimated using survival methods with patients censored 
if they died in hospital. ^ excluding patients that died in theatre. ‡GA: n=6992 RA: n=2343 LA: n=367. ‖ GA: n=1231 RA: 







Data available from the NVR registry. 
Hospital code, sex, age at time of surgery, mode of admission, weight, height, AAA size, previous aortic 
operation, comorbidities (diabetes, hypertension, chronic lung disease, ischaemic heart disease, chronic 
heart failure, chronic renal disease, stroke), smoking status, white cell count, sodium, potassium, 
creatinine, albumin, haemoglobin, abnormal ECG, ASA grade, pre-operative medication, month and year of 
procedure, day of procedure, start time, AAA status, type of repair, anaesthetic type, procedure code 1, 
EVAR exclusion, type of EVAS device, neck angle, neck diameter, neck length, extended EIA, CIA diameter, 
type of complex EVAR, iliac branch, endoleak type, endoleak intervention, endoleak intervention success, 
AAA clamp site, AAA graft type, direct arterial monitoring, intraoperative cardiac output monitoring, 
postoperative coagulopathy, postoperative core temperature ≥ 36°C, patient reported severe pain within 1 
hour of surgery, postoperative vomiting within 3 hours, destination after surgery, critical care stay, return 
to theatre within admission, re-admission to higher level of care, postoperative complications (cardiac, 
respiratory,  cerebral, renal failure, haemorrhage, limb ischaemia, paraplegia, bowel ischaemia, puncture 
site haematoma, false aneurysm, vessel perforation, distal embolus), discharge status (alive of discharge), 
re-admission to hospital within 30 days, date clinic appointment attended, reason for no follow-up, length 




Table 1. Hospital use of anaesthesia according to AAA abdominal aortic aneurysm (AAA) caseload. 
 General Anaesthesia Regional Anaesthesia Local Anaesthesia 
 Used for 
elective 
EVAR (n=87) 












Not used for 
elective EVAR 
(n=32) 




















































19.5 (8.9, 28.2) 
Data are presented as median (Interquartile range).  AAA= Abdominal aortic aneurysm. EVAR= Endovascular aneurysm 
repair.  
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Table 2. Patient characteristics and operative characteristics of patients receiving elective standard infra-renal 
EVAR (n=9783) 
 GA General 
Anaesthesia  
(n=7069)  
 RA Regional 






















(89.1)% 0.01 0.03 
Smoker 










(16.4)% -0.04 -0.07 



















(13.4)% -0.03 -0.12 









(0.3)% -0.01 -0.08 









(15.8)% -0.10 -0.24 
 






















(19.1)% 0.10 0.41 
 V: Moribund patient 2/7067 (0.0)% 1/2347 (0.0)% 
2/36
7 
(0.5)% 0.01 0.10 
CARDIOVASCULAR RISK FACTORS*  







































(8.7)% -0.03 0.06 









(51.0)% 0.05 0.21 









(16.1)% 0.11 0.36 









(15.8)% 0.08 0.07 









(36.2)% 0.29 0.28 
AAA ANATOMY†  
AAA diameter (mm) ¶* 
Median 
(IQR) 
60 (56, 66) 60 (56, 65) 60 (57, 68) 0.02 0.10 
Neck length (mm) §¥ 
Median 
(IQR) 
23 (17, 30) 24 (17, 30) 23 (17, 30) -0.01 -0.03 
Neck diameter (mm)× 
Median 
(IQR) 
24 (22, 27) 24 (22, 26) 24 (21, 27) -0.07 -0.10 
Common iliac artery 
diameter (mm) ~ 
Median 
(IQR) 
15 (13, 18) 15 (13, 18) 15 (12, 18) -0.02 -0.06 
BRITISH ANEURYSM REPAIR SCORE (BAR SCORE) †  























Data are presented as n (%)* or median (Interquartile range) † unless otherwise stated. RA= Regional Anaesthesia. GA= 
General Anaesthesia. LA = Local Anaesthesia. SMD = Standardized mean difference. EVAR = Endovascular aneurysm 
repair. AAA= abdominal aortic aneurysm. RA – regional anaesthesia, GA – general anaesthesia, LA local anaesthesia. SMD 
– Standardized Mean Difference  
 
Missing data (GA, RA, LA): ‡ 
^ Data missing for 32 patients (25, 6, 1), ¶* data missing for 1 patient (1, 0, 0), §¥ data missing for 212 patients (195, 13, 4), 
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Table 3. Post-operative outcomes for elective EVAR. 
 GA General 
Anaesthesia 
(n=7069)  
 RA Regional 
Anaesthesia   
(n=2347) 
LA Local Anaesthesia  
(n=367) 
OUTCOMES    
In-hospital death  58  13  4  
In hospital death within 30-days† 50 (0.9) 11 (0.6) 3 (1.5) 
7-day mortality§ % (95% CI) 0.57% (0.4, 0.8) 0.3% (0.1, 0.6) 0.4% (0.1, 2.6) 





2.0 (2.0, 4.0) 2.0 (1.0, 4.0) 2.0 (1.0, 4.0) 
Admitted to 
ICU^† 
 1618/5394 (30.0)% 720/1984 (36.3)% 123/321 (38.3)% 




1.0 (1.0, 2.0) 1.0 (1.0, 2.0) 1.0 (1.0, 2.0) 
Readmission within 30 days of 
discharge† 
340/5825 (5.8)% 142/2074 (6.8)% 34/313 (10.9)% 
COMPLICATIONS† n=7068 n=2346 n=367 
Cardiac complications 136/7068 (1.9)% 36/2346 (1.5)% 8/367 (2.2)% 
Pulmonary 
complications 
 163/7068 (2.3)% 63/2346 (2.7)% 11/367 (3.0)% 
Cerebral 
complications 
 12/7068 (0.2)% 6/2346 (0.3)% 1/367 (0.3)% 
Renal failure  98/7068 (1.4)% 38/2346 (1.6)% 5/367 (1.4)% 
Bleeding  74/7068 (1.0)% 15/2346 (0.6)% 4/367 (1.1)% 
        
Number of 
complications 
None 5504 (77.9) 1953 (83.2) 302 (82.3) 
1 1439 (20.4) 357 (15.2) 57 (15.5) 
 2 101 (1.4) 31 (1.3) 6 (1.6) 
 3 23 (0.3) 5 (0.2) 0 (0.0) 
 4 1 (0.0) 0 (0.0) 2 (0.5) 
        
Endoleak‡   1231/6992 (17.6)%  276/2343 (11.8)% 48/363 (13.2)% 
Endoleak type‖ Type 1 368/1231 (29.9)% 79/276 (28.6)% 17/48 (35.4)% 
Type 2 776/1231 (63.0)% 185/276 (67.0)% 24/48 (50.0)% 
Type 3 29/1231 (2.4)% 5/276 (1.8)% 2/48 (4.2)% 
Type 4 27/1231 (2.2)% 2/276 (0.7)% 3/48 (6.3)% 
Unclassified 31/1231 (2.5)% 5/276 (1.8)% 2/48 (4.2)% 
Data are presented as n (%)†, percent (95% confidence interval)§ and median (Interquartile range)¶ unless otherwise 
stated. RA= Regional Anaesthesia. GA= General Anaesthesia. LA = Local Anaesthesia. LOS= Length of Stay. ICU= 
Intensive care unit.  EVAR= Endovascular aneurysm repair.RA – regional anaesthesia, GA – general anaesthesia, LA 
local anaesthesia, LOS – length of stay; ICU – Intensive care unit  
* estimated using survival methods with patients censored if they died in hospital.   
















Data available from the NVR registry. 
Hospital code, sex, age at time of surgery, mode of admission, weight, height, AAA size, previous aortic 
operation, comorbidities (diabetes, hypertension, chronic lung disease, ischaemic heart disease, chronic 
heart failure, chronic renal disease, stroke), smoking status, white cell count, sodium, potassium, 
creatinine, albumin, haemoglobin, abnormal ECG, ASA grade, pre-operative medication, month and year of 
procedure, day of procedure, start time, AAA status, type of repair, anaesthetic type, procedure code 1, 
EVAR exclusion, type of EVAS device, neck angle, neck diameter, neck length, extended EIA, CIA diameter, 
type of complex EVAR, iliac branch, endoleak type, endoleak intervention, endoleak intervention success, 
AAA clamp site, AAA graft type, direct arterial monitoring, intraoperative cardiac output monitoring, 
postoperative coagulopathy, postoperative core temperature ≥ 36°C, patient reported severe pain within 1 
hour of surgery, postoperative vomiting within 3 hours, destination after surgery, critical care stay, return 
to theatre within admission, re-admission to higher level of care, postoperative complications (cardiac, 
respiratory,  cerebral, renal failure, haemorrhage, limb ischaemia, paraplegia, bowel ischaemia, puncture 
site haematoma, false aneurysm, vessel perforation, distal embolus), discharge status (alive of discharge), 
re-admission to hospital within 30 days, date clinic appointment attended, reason for no follow-up, length 
of stay, post-operative length of stay, vascular specialist 1, vascular specialist 2, vascular specialist 3.  
 
Appendix 1 
Data available from the NVR registry. 
Hospital code, sex, age at time of surgery, mode of admission, weight, height, AAA size, previous 
aortic operation, comorbidities (diabetes, hypertension, chronic lung disease, ischaemic heart 
disease, chronic heart failure, chronic renal disease, stroke), smoking status, white cell count, 
sodium, potassium, creatinine, albumin, haemoglobin, abnormal ECG, ASA grade, pre-operative 
medication, month and year of procedure, day of procedure, start time, AAA status, type of repair, 
anaesthetic type, procedure code 1, EVAR exclusion, type of EVAS device, neck angle, neck diameter, 
neck length, extended EIA, CIA diameter, type of complex EVAR, iliac branch, endoleak type, 
endoleak intervention, endoleak intervention success, AAA clamp site, AAA graft type, direct arterial 
monitoring, intraoperative cardiac output monitoring, postoperative coagulopathy, postoperative 
core temperature ≥ 36°C, patient reported severe pain within 1 hour of surgery, postoperative 
vomiting within 3 hours, destination after surgery, critical care stay, return to theatre within 
admission, re-admission to higher level of care, postoperative complications (cardiac, respiratory,  
cerebral, renal failure, haemorrhage, limb ischaemia, paraplegia, bowel ischaemia, puncture site 
haematoma, false aneurysm, vessel perforation, distal embolus), discharge status (alive of 
discharge), re-admission to hospital within 30 days, date clinic appointment attended, reason for no 
follow-up, length of stay, post-operative length of stay, vascular specialist 1, vascular specialist 2, 
vascular specialist 3.  
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